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The dopamine (DA) transporter (DAT) serves to clear released DA from the 
synaptic cleft and is an important part of the mesolimbic DA system, which mediates the 
rewarding and reinforcing effects of various drugs of abuse. Several studies suggest that 
the function of DAT is regulated by protein-protein interactions and signaling systems 
that alter cellular trafficking of DAT. Ethanol potentiates DAT function in Xenopus 
oocytes expressing DAT in a manner consistent with altered cellular trafficking. In 
contrast to ethanol’s effects on DAT, the function of the related norepinephrine 
transporter (NET) is inhibited by ethanol. To delineate mechanisms of ethanol action on 
DAT, chimeras were generated between DAT and NET. The results of these as well as 
site directed mutagenesis experiments revealed ethanol sensitive sites in the first 
 vi
intracellular loop of DAT. The absence of consensus phosphorylation sites in this loop 
led to the hypothesis that ethanol modulates the interaction between DAT and a putative 
regulatory protein important for ethanol-induced trafficking of DAT and that this 
interaction occurs at the first intracellular loop. To identify proteins and signaling 
pathways that might regulate DAT function, an interaction proteomics based approach 
was used to isolate and identify proteins associated with DAT. These studies revealed 
that DAT is part of a large multiprotein complex consisting of 21 proteins that can be 
classified as ion channels, trafficking proteins, extracellular matrix associated and 
cytoskeletal proteins. Finally, the effects of ethanol on DAT trafficking were ascertained 
by examining ethanol-induced changes in DAT function in several cell types. Studies on 
MDCK cells stably expressing GFP-DAT suggest that ethanol potentiates DAT function 
in this cell type. SH-SY5Y cells stably expressing DAT were also examined for ethanol 
effects on DAT function. Ethanol produced a 25% enhancement in DAT function in these 
cells, which was not statistically significant. The effects of ethanol on DAT trafficking in 
neuronal cells were observed by using a sindbis viral construct encoding GFP-DAT. The 
experiments outlined above have led to the identification of a novel role for DAT in 
ethanol-induced neuroadaptation and in the identification of several novel proteins that 






Table of Contents 
Abbreviations  xi
   
Chapter 1 Introduction 1
 1.1 Cellular localization of 
DAT 
2
 1.2 Structure and function of DAT 3
  1.2.1 Structural basis of DA uptake 3
  1.2.2 Structural basis for substrate binding and translocation 7
  1.2.3 Oligomerization of DAT 8
  1.2.4 Glycosylation of DAT 9
 1.3 Effects of psychostimulants on DAT function 10
 1.4 Regulation of DAT 11
  1.4.1 Regulation by PKC and other kinases 11
  1.4.2 Regulation by substrates and drugs of abuse 12
 1.5 Protein interactions that modulate DAT 
function 
13
 1.6 Mass spectrometry-based proteomics 15
 1.7 Ethanol and dopaminergic systems 17
 1.8 Research aims 18
 1.9 Chapter overview 20
   
Chapter 2 Materials and methods 23
 2.1 Transporter chimeras 23
 2.1 Substrate uptake in transfected mammalian 
cells 
23
 2.3 cRNA preparation and oocyte injection 25
 2.4 Site directed mutagenesis 25
 2.5 [3H]DA uptake in Xenopus oocytes 25
 2.6 [3H]WIN 35,428 binding in Xenopus oocytes 26
 2.7 Materials for proteomics 26
 2.8 Co-immunoprecipitation of the DAT complex 27
 2.9 Crude synaptosome preparation 28
 2.1 Preparation of protein samples 28
 2.11 Mass spectrometry 29
 2.12 Strategy for protein identification 29
 2.13 In Silico analysis of DAT transcriptome 30
 2.14 Generation of sindbis viral constructs encoding GFP-DAT 30
 2.15 [3H]DA uptake in BHK cells and MDCK  31
 viii
  cells expressing GFP-DAT
 2.16 Preparation and infection of explant cultures with Virions 31
 2.17 Preparation and infection of midbrain DA neurons in culture 32
 2.18 Fluorescence imaging 32
 2.19 Generation of stably transfected cell lines 33
   
Chapter 3 Ethanol modulation of human dopamine transporter function 34
 3.1 Introduction 34
 3.2 Effect of ethanol on WT DAT and NET expressed  36
  in HeLa cells 
 3.3 Structural domains essential for ethanol potentiation  36
  of DAT 
function 
 3.4 Site directed mutagenesis of DAT 41
 3.5 Discussion 48
   
Chapter 4 Defining the dopamine transporter proteome by convergent 54
 biochemical and in silico analysis 
 4.1 Introduction 54
 4.2 Isolation and validation of the DAT proteome 56
 4.3 Mass spectrometry 58
 4.4 Confirmation of members of the DAT proteome 60
 4.5 In silico analysis of the DAT 
proteome 
64
 4.6 Discussion 69
   
Chapter 5 Characterization of ethanol effects in mammalian cells expressing DAT 76
 5.1 Introduction 76
 5.2 Effects of ethanol on MDCK cells stably expressing GFP-DAT 76
 5.3 Effects of ethanol on SH-SY5Y cells stably expressing GFP-DAT 79
 5.4 Generation of sindbis viral particles encoding GFP-DAT 82
  5.4.1 Effects of ethanol on GFP-DAT expressed in mouse  87
   midbrain DA neurons 
 5.6 Discussion 89
   
Chapter 6 Discussion 92
 6.1 Ethanol's effects on dopaminergic synaptic transmission 92
 6.2 Ethanol's effects on DAT expressed in Xenopus oocytes 95
 6.3 Ethanol's effects on DAT function in mammalian cells expressing 98
  DAT 
 ix
 6.5 The dopamine transporter proteome 100
   
 Bibliography 106






















List of Abbreviations 
 
DAT   Dopamine transporter 
DA   Dopamine 
[3H]WIN 35,428 2β Carbomethoxy-3β-(4-fluorophenyl)[3H] tropane, 
NET   Norepinephrine transporter 
SERT   Serotonin transporter 
GLYT   Glycine transporter 
PKC   Protein kinase C 
PKA   Protein kinase A 
NMDA  N-Methyl D-Apartate 
5HT2C   Serotonin 2C receptor 
TMD   Transmembrane domain 
G130T   Glycine at position 130 mutated to threonine 
F123Y   Phenylalanine at position 123 mutated to tyrosine 
I137F   Isoleucine at position 137 mutated to phenylalanine 
L138F   Leucine at position 138 mutated to phenylalanine 
VTA   Ventral tegmental area 
NAc   Nucleus accumbens 
aCSF   Artificial cerebrospinal fluid 
 
PICK1   Protein interacting with C Kinase 1 
 
Hic-5   Hydrogen peroxide-inducible protein 5 
 xi
 
PCA   Principal component analysis 
 
GFP   Green fluorescent protein 
 
MDCK   Madin Darby canine kidney cells 
 






Neurons rely upon chemical neurotransmitters for rapid  (order of milliseconds) 
and precise communication with each other and with target organs. Neurotransmitters 
released into the synaptic cleft activate specific receptors on the postsynaptic neuron, 
which in turn causes opening of ion channels and activation of signal transduction 
cascades in the post-synaptic cell (Kandel et al., 1991), resulting in transmission of the 
signal.  The lifetime of the neurotransmitter released into the synaptic cleft is 
predominantly regulated by specific proteins that mediate their reuptake into the 
presynaptic cell. Julius Axelrod was the first to introduce the concept of reuptake by 
demonstrating that synaptically released noradrenaline is taken up by specific transporters 
in sympathetic nerve terminals (Hertting and Axelrod, 1961). Subsequently, reuptake 
mechanisms have been discovered for serotonin, dopamine (DA), γ-amino butyric acid 
(GABA), glycine and a number of other neuromodulators. Neurotransmitter transporters 
have been shown to play a very important role in sculpting the temporal and spatial 
aspects of neurotransmission. They are also the sites of action of various 
psychostimulants and therapeutic agents used for treating attention deficit hyperactivity 
disorder and depression (Torres et al., 2003b).  
The DA transporter (DAT) belongs to the family of Na+ and Cl- dependent 
transporters and functions to clear released DA from the synaptic cleft and effectively 
reduce the concentration of dopamine at both pre- and post-synaptic dopamine receptors 
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(Nelson, 1998) . Thus, DAT regulates the spatial and temporal aspects of dopaminergic 
synaptic transmission and is an integral part of the mesostriatal DA system. This system 
plays a central role in mediating the rewarding and reinforcing effects of various drugs of 
abuse such as ethanol (Brodie and Appel, 1998; Brodie et al., 1990; Weiss et al., 1993). 
DAT is also the site of action for various psychostimulants like cocaine, mazindol, 
methylphenidate and amphetamine (Nelson, 1998). These findings underscore the 
importance of DAT in mediating the effects of these drugs of abuse. 
 
1.1 Cellular localization of DAT 
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DAT is exclusively expressed in midbrain dopaminergic neurons where it is 
expressed in the cell bodies, dendrites and axonal membranes. Midbrain dopaminergic 
neurons originate in the substantia nigra and ventral tegmental area (VTA) region and 
project mainly to the striatum, nucleus accumbens (NAc), amygdala, and the prefrontal 
cortex (Bonci et al., 2003; Wise, 2002). DAT is localized to the plasma membrane and 
smooth endoplasmic reticulum of dendrites and dendritic spines in the substantia nigra 
(Nirenberg et al., 1996). The subcellular distribution of DAT in the VTA is very similar 
to that in the substantia nigra, with most of the labeling found to be associated with 
plasma membranes of dendrites and dendritic spines (Nirenberg et al., 1997b). DAT is 
expressed highly in the striatum. It is estimated that there are 150-300 molecules µm-3 of 
DAT in the striatum (Cragg and Rice, 2004).  Immunogold labeling of DAT in the 
dorsolateral striatum was localized to the axons and axon terminals (Nirenberg et al., 
1996). In the NAc, differential expression of DAT is observed in the NAc shell region as 
 
compared to the core. A majority of the labeled DAT was found to be associated with the 
cytoplasmic surfaces of axons, however small amounts of DAT immunoreactivity were 
also associated with small synaptic vesicles in this brain region (Nirenberg et al., 1997a).  
The presence of DAT in intracellular compartments suggests that targeting mechanisms 
exist to transport DAT to specific perisynaptic sites. 
 
1.2 Structure and function of DAT 
 
 
Monoamine transporters including DAT are integral membrane proteins. 
Hydrophobicity analysis predicts that DAT contains 12 transmembrane domains (TMD) 
(Giros and Caron, 1993). The N- and C-termini of the transporter are intracellular and a 
large extracellular loop between TMD3 and TMD4 contains several consensus 
glycosylation sites (Figure 1). DAT mediates uptake of DA as well as NE, although the 
uptake of NE is inefficient compared to DA (Chen et al., 2004). Other substrates include 
amphetamine and the neurotoxin 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine (MPTP). 
An overview of the mechanism of DA uptake as well as the amino acid residues 
implicated in substrate binding and translocation is included in this section. 
 
1.2.1 Structural basis of DA uptake 
 
 
Transport of DA by DAT is dependent upon extracellular Na+ and Cl- ions.  
During a transport cycle, two Na+, one Cl- and one charged molecule of DA bind to the 
transporter and are translocated resulting in the net movement of two positive charges per 
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molecule of DA. The driving force for DA uptake by DAT is generated by the plasma-
membrane protein Na+, K+-ATPase, which pumps Na+ out and K+ into the cell (Chen and 
Reith, 2003). The exact mechanism and regions of the transporter involved in this 
coupled transport process remain unclear. A crystal structure is not available currently for 
any member of the Na+/Cl-dependent neurotransmitter transporter family. A wide variety 
of techniques including substituted cysteine accessibility method and zinc site 
engineering have been employed to delineate amino acid sequences and mechanisms 
important for the transport process. Electrophysiological studies indicate that some 
aspects of DAT function can be compared to ion-channel like mechanisms. Several 
models have been proposed to explain the channel-like properties of DAT. The most 
accepted of these is the alternating access model. In this model a transporter is thought to 
resemble a channel but with gates at both the cytoplasmic and the extracellular end. The 
gates open sequentially to allow binding of substrates and ions and hence produce 
coupled transport (Lester et al., 1996). The transport rates for DA transport by DAT are 
relatively modest and estimated to be 2-5 molecules of DA per second per molecule of 
DAT (Cragg and Rice, 2004).  
Studies of transporter-associated currents in heterologous systems suggest at least 
three different conductances: 1) a substrate coupled conductance 2) a constitutive leak 
conductance that is blocked by both substrates and inhibitors of the transporter and 3) 
uncoupled transport-associated conductance (Ingram et al., 2002). A physiological role 
for these DAT associated conductances was recently highlighted by two studies. The first 
study suggests that synaptic activation of somatodendritic DA release in the substantia 
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nigra is due to DAT-mediated reverse transport of DA. However, the mechanism by 
which DAT function is reversed to cause DA efflux remains unclear (Falkenburger et al., 
2001). A second study describes an endogenous DAT-mediated anion conductance in rat 
midbrain DA neurons in culture. The anion conductance promotes excitability of DA 
neurons in culture and suggests an alternative mechanism for DAT-mediated release of 
DA (Ingram et al., 2002). Clearly, the demonstration of multiple conducting states of the 
































Figure 1: Schematic of the DAT with positions of amino acid residues important for 
substrate and Zn2+ binding, ethanol modulation of DAT function, PKC phosphorylation, 







DA uptake by DAT has been shown to be dependent upon the membrane 
potential (voltage dependent) in expression systems. In Xenopus oocytes expressing 
DAT, DA uptake increases with hyperpolarization and decreases with depolarization 
(Sonders et al., 1997). However, a correlation between membrane potential and DAT 
function has not been observed under more physiological conditions in cultured 
dopamine neurons (Prasad and Amara, 2001). Activation of the dopamine D2 
autoreceptor has also been shown to inhibit DAT and affect DA clearance. D2 
antagonists have been shown to inhibit DAT function in brain (Cass and Gerhardt, 1994) 
and in slice preparations (Meiergerd et al., 1993).  D2 regulation of DAT function has 
been shown to be voltage-independent and likely involves second messenger systems 
(Mayfield and Zahniser, 2001). 
 
1.2.2 Structural basis for substrate binding and translocation. 
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Chimeric constructs between DAT and NET were utilized to identify regions on 
the transporter important for substrate binding, translocation, and cocaine affinity (Buck 
and Amara, 1994; Buck and Amara, 1995; Giros and Caron, 1993). These studies suggest 
that a region of the transporter encompassing TMD6 through TMD8 is important for 
cocaine affinity while amino acid residues spanning TMD9 through the carboxyl-terminal 
tail are important for high affinity substrate binding. The regions of the transporter 
important for substrate translocation are somewhat controversial with one study 
implicating a region spanning TMD4 through TMD8 (Giros et al., 1994) and another 
study suggesting that the first five transmembrane domains are important for this function 
 
(Buck and Amara, 1994). Studies utilizing chimeras between human and bovine DAT 
also implicate TMD3 in DA uptake. Amino acid residue D79 in the first TMD also seems 
to be important for substrate binding (Loland et al., 2002).  
Accessibility of native cysteines to thiol-reactive componds (MTSET, MTSEA) 
and Zn2+-site engineering have been used to examine the conformational changes 
associated with substrate binding and translocation. Experiments with thiol-specific 
reagents have revealed that the amino acid residue at position 342 is involved in 
conformational changes that accompany substrate translocation.  Mutation of a tyrosine 
(Y335) residue in the third intracellular loop has also been shown to abolish DA uptake 
suggesting a role for this loop in substrate translocation (Chen et al., 2000). Experiments 
have also revealed that Zn2+ in µM concentrations is a potent inhibitor of DA transport. 
Three residues have been implicated in forming a tridentate Zn2+ binding site on DAT. 
These include histidine at position 193 in the second extracellular loop, histidine at 
position 375 in TM7 and glutamate at position 396 in TM8. Although these residues 
appear to be far apart their role in Zn2+ binding suggests that these residues are in close 
proximity in the tertiary structure of DAT. Recent studies also suggest that Zn2+ can also 
enhance an uncoupled chloride conductance associated with DAT in Xenopus oocytes 
expressing DAT (Bjerggaard et al., 2004; Meinild et al., 2004). 
 
1.2.3 Oligomerization of DAT 
 
Recent studies indicate that DAT at the cell membrane can exist as a multimer 
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(Hastrup et al., 2001). Several regions of the transporter have been implicated in 
oligomerization of DAT. A glycophorin-like motif in TMD6 has been implicated in the 
formation of DAT dimers. This was demonstrated by symmetrical crosslinking of 
cysteine residues in the extracellular face of TMD6 (Hastrup et al., 2001). It has been 
shown that mutations in the leucine repeat region of TMD2 can abolish plasma 
membrane delivery of DAT and these mutants also display a dominant negative 
phenotype when co-expressed with wild type DAT (Torres et al., 2003a). Fluorescence 
resonance energy transfer (FRET) studies of tagged human DAT molecules have shown 
that DAT can exist as an oligomer in the endoplasmic reticulum (ER) and that DAT is 
internalized as an oligomer upon treatment with drugs like amphetamine, cocaine, and 
phorbol esters (Sorkina et al., 2003). Recent cysteine cross-linking experiments have 
shown that DAT may exist at the cell surface as a tetramer composed of two symmetrical 
homo-dimers (Hastrup et al., 2003). These results suggest that discrete regions on the 
transporter are involved in transporter oligomerization and reiterate the importance of 
DAT oligomerization for steady state trafficking of DAT to the cell surface. 
 
1.2.4 Glycosylation of DAT 
 
DAT is a heavily glycosylated (glycosylation accounts for ~ 30% of the molecular 
weight of DAT) protein in vivo. The large extracellular loop between TMD3 and TMD4 
has three asparagine residues at position 181, 188, and 205 which are glycosylated (Giros 
et al., 1994). Functional analysis of a mutant transporter in which all three of the 
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asparagine residues were mutated to alanine revealed that these residues are important for 
proper trafficking of the transporter to the cell surface. However, the fraction of the 
mutant transporters that were expressed on the cell surface were able to function 
normally suggesting that glycosylation is important for cell surface expression but not 
substrate affinity (Torres et al., 2003a). 
 
1.2 Effects of psychostimulants on DAT function 
 
Several psychostimulants and drugs of abuse mediate their effects by interfering 
with the DA uptake process. Cocaine is a potent inhibitor of DAT function (Loland et al., 
2002). Cocaine competes with DA for DAT binding and hence competitively inhibits DA 
transport. Amino acid residues on DAT that mediate cocaine binding are not fully 
understood.  An aspartate residue at position 79 is important for cocaine affinity of DAT 
(Loland et al., 2002). Amphetamine is a DAT substrate and is transported into the cell. 
Once inside the cell, amphetamine can, by mechanisms that are not clearly understood, 
cause efflux of DA from vesicular stores into the cytoplasm, and release of DA by DAT 
by reverse transport (Torres et al., 2003b). Hence, both cocaine and amphetamine can 
cause an increase in extracellular DA concentrations which is thought to mediate the 
rewarding and reinforcing properties of these drugs (Torres et al., 2003b). Cocaine has 
also been shown to be rewarding in DAT-knockout animals suggesting the presence of 




1.4  Regulation of DAT 
 
 A number of studies in recent years suggest that cell surface DAT levels can be 
regulated acutely by a number of different second messenger pathways both in vitro and 
in vivo. This mechanism of regulation of transporter function could potentially play an 
important role physiologically because the uptake of DA by DAT is a slow process 
(Cragg and Rice, 2004) and an acute increase in the cell surface expression of DAT may 
facilitate the clearance of DA released during burst firing (Mortensen and Amara, 2003).  
 
1.4.1 Regulation by PKC and other kinases 
 
Activation of protein kinase C (PKC) by phorbol esters has been shown to induce 
a rapid downregulation of DAT in several cells and striatal synaptosomal preparations 
(Daniels and Amara, 1999; Melikian and Buckley, 1999; Zhu et al., 1997). This has been 
shown to be a dynamin- and clathrin-dependent process (Daniels and Amara, 1999). The 
fate of the internalized transporters is somewhat controversial with one study reporting 
that the internalized transporters are targeted to lysosomes for degradation (Daniels and 
Amara, 1999) and another study reporting that transporters are internalized into 
endosomes that are recycled to the cell surface (Melikian and Buckley, 1999). In PC12 
cells transporters are constantly in a state of flux, constitutively endocytosing and then 
recycling back to the cell surface. Upon activation of PKC, endocytosis of DAT is 
enhanced and the recycling of endocytosed DAT to the cell surface is inhibited (Loder 
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and Melikian, 2003). The DAT sequence has several consensus sites for phosphorylation 
by PKC and protein kinase A (PKA, (Giros and Caron, 1993)). Mutagenesis studies have 
shown that these consensus sites are not essential for PKC-mediated internalization of 
DAT, suggesting a role for accessory proteins in PKC-regulation of DAT function 
(Chang et al., 2001). A recent study suggests that deletion of the N-terminus of the 
transporter results in a mutant transporter with normal DA uptake characteristics but 
impaired PKC regulation (Granas et al., 2003). Acute exposure to PKC inhibitors have 
also shown to inhibit amphetamine-mediated DA efflux in rat striatal slices in a calcium- 
and DAT-dependent manner (Kantor and Gnegy, 1998).  
Stimulation of adenylyl cyclase by forskolin has been shown to stimulate DA 
transport in rat striatal tissue in a PKA-dependent manner (Batchelor and Schenk, 1998). 
Protein tyrosine kinases have also been implicated in regulating DAT function in a 
manner consistent with altered cellular trafficking. Inhibition of protein tyrosine kinases 
results in a decrease in DAT function. Phophatidylimosital-3-kinase and mitogen 
activated protein kinase (MAPK) pathways have also been implicated in regulating DAT 
function (Carvelli et al., 2002; Lin et al., 2003). 
 
1.4.2 Regulation by substrates and drugs of abuse 
 
Drugs of abuse like amphetamine can also regulate DAT function by causing 
internalization of cell surface transporters in a dynamin- and clathrin-dependent manner 
(Saunders et al., 2000). Experiments carried out in human embryonic kidney (HEK) cells 
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demonstrated that acute exposure to cocaine enhances DAT activity in a time-dependent 
manner by increasing the number of functional transporters at the cell surface (Daws et 
al., 2002). Cocaine also increases the number of DAT binding sites in neuro 2A (N2A) 
cells by altering the intracellular trafficking of DAT (Little et al., 2002). Dopamine has 
also been shown to regulate DAT expression levels. In HEK cells expressing DAT, 
exposure to DA has been shown to cause internalization of DAT (Saunders et al., 2000). 
Repeated exposure to DA has been shown to cause a decrease in DAT associated currents 
in Xenopus oocytes expressing DAT. DAT mediated DA clearance in vivo was also 
inhibited by repeated exposure to substrates (Gulley and Zahniser, 2003). The results 
outlined in this section suggest that alterations in membrane trafficking predominantly 
regulate DAT function at the cell surface. Hence, an understanding of signaling pathways 
and proteins that modulate DAT trafficking would aid in the development of therapeutic 
agents that could modulate DAT function. 
 
1.5 Protein interactions that modulate DAT function 
 
Thus, there is substantial evidence that DAT undergoes regulated trafficking both 
in vitro and in vivo, and this may be important for the functional and pharmacological 
sensitivity of the transporter. It is likely that transporter-interacting proteins play a key 
role in these modes of regulation. The DAT sequence contains numerous motifs for 
protein-protein interactions, including a PDZ binding domain at the C-terminus, an N-
terminal leucine repeat and two di-leucine motifs (Torres et al., 2003b). Currently, three 
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proteins have been identified that alter DAT function by interacting directly with the 
transporter. These proteins were identified by the yeast two-hybrid approach using the C-
terminal tail of DAT as bait. These are α-synuclein, the PDZ domain containing protein 
PICK1 (protein interacting with C kinase 1) and Hic-5 (hydrogen peroxide-inducible 
protein 5). PICK1 potentiates DAT function by enhancing cell surface distribution of the 
transporters in cultured neuronal cells and in HEK293 cells. PICK1 was originally 
identified as a protein that interacts with the catalytic domain of PKC-α (Torres et al., 
2001). A recent study however suggests that the PDZ domain of DAT (and hence its 
interaction with PICK1) is not necessary for normal surface targeting of DAT in HEK293 
cells and in N2A cells (Bjerggaard et al., 2004). It is possible that PICK1 could play a 
modulatory role in PKC-mediated regulation of DAT function. The interaction of DAT 
with Hic5 results in inhibition of DAT function by downregulating the number of cell 
surface transporters. Hic5 is a LIM-domain containing adaptor protein that has been 
shown to interact with several kinases like focal adhesion kinase and fyn kinase. Hence, 
Hic5 could play a role in linking DAT to diverse cell signaling pathways (Carneiro et al., 
2002). α-Synuclein was the first protein that was shown to interact with the c-terminal 
tail of DAT (Lee et al., 2001). The functional consequence of DAT-α-synuclein 
interaction remains controversial with one group suggesting that DAT-interaction with α-
synuclein enhances clustering of DAT and cellular uptake of DA (Lee et al., 2001); 
however, one study suggests that α-synuclein inhibits DAT function (Wersinger and 
Sidhu, 2003). Recent studies suggest that synaptic proteins function as part of 
multiprotein complexes. For example, the NMDA receptor is part of a protein complex 
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comprising of 77 proteins (Husi et al., 2000). It is likely that DAT is also part of a large 
multiprotein complex and a proteomics-based approach could aid in elucidating 
components of the DAT proteome. 
 
1.6 Mass spectrometry-based proteomics 
 
The term proteome refers to the set of all proteins expressed in a cell at a given 
time under a given set of conditions (Mann et al, 2003). Mass spectrometry is an 
analytical technique used to identify proteins by accurately determining the mass of 
fragments obtained by proteolytic digestion of the proteins and comparing the mass 
obtained to theoretical digests of known and predicted proteins in databases. Proteomics 
can be classified into two types: expression and interaction proteomics. Expression 
proteomics refers to large-scale studies of variations in protein expression. Interaction 
proteomics refers to the identification of protein–protein interactions within a cell 
(Aebersold and Mann, 2003). Protein-protein interactions can be enriched by antibody 
based or affinity purification techniques. The classical method for identifying protein-
protein interactions is the yeast two-hybrid method, in which the bait proteins are 
expressed as a fusion to the DNA-binding domain of a yeast transcription factor and the 
cDNA library insert is expressed as a fusion protein to the activation domain of the 
transcription factor. Interaction between the bait and library proteins results in the 
activation of the transcription factor and a reporter gene. The yeast two-hybrid technique 
has been used successfully in biology to identify protein-protein interactions and is 
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amenable for high throughput applications. Mass spectrometry based approaches has 
advantages over the classical yeast two hybrid approaches in that the interactions are 
identified in authentic cellular contexts, and hence do not require extensive validations 
(Mann et al, 2003). Mass spectrometry is very sensitive and highly accurate and can 
identify proteins whose abundance is in the low femtomole levels.  
Two most commonly used mass spectrometry approaches are MALDI (Matrix 
Assisted Laser/Desorption Ionization) and ESI (Electrospray Ionisation) mass 
spectrometry. The techniques differ in the methods used for ionization of peptides. 
MALDI analysis requires the digested sample to be mixed in a UV-absorbing matrix and 
the peptides are ionized with a UV laser beam. In case of ESI, the peptide solution is 
ionized by high voltages to form multiply protonated species (Rappsilber et al., 2003). 
Thus, ESI has higher mass accuracy than MALDI. The first step in identifying a protein 
by mass spectrometry is to digest the protein with a specific protease such as trypsin. The 
resulting peptides are then introduced into a mass spectrometer where they are ionized 
and their masses are measured. Sequence information is generated by tandem mass 
spectrometry where ions of interest are selected, fragmented, and the masses of the 
fragmented ions are used to generate an MS/MS or daughter spectrum. Complete 
sequence information of the entire protein is not determined by mass spectrometry but 
sequence information obtained from a few peptides is used to query a database and 
identify the protein (Perkins et al., 1999). Mass spectrometry based approaches have been 
used successfully to elucidate the NMDA receptor proteome (Husi et al., 2000) and the 
5HT2c receptor proteome (Becamel et al., 2002). Novel interaction partners for the Ca2+-
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activated potassium channel were also identified using an interaction-proteomics based 
approach (Becamel et al., 2002). 
 
1.7 Ethanol and dopaminergic systems 
 
A number of studies suggest that ethanol can affect the firing of midbrain DA 
neurons (Brodie and Appel, 1998; Brodie et al., 1990; Weiss et al., 1993). The resulting 
increase in extracellular DA is thought to mediate the rewarding and reinforcing effects 
of ethanol. However, recent studies also suggest that increase in extracellular DA 
concentrations may not correlate with reward (Cannon and Bseikri, 2004). Self-
administration of ethanol in alcohol-preferring rats and genetically heterogeneous wistar 
rats has been shown to increase levels of extracellular DA (Gonzales and Weiss, 1998; 
Katner et al., 1996). Since, DAT is the primary mechanism for DA uptake, an ethanol-
induced change in DAT function could also profoundly affect dopaminergic synaptic 
transmission. Ethanol affects the function of several members of the Na+ and Cl- 
dependent family of transporters. Experiments in HEK-293 cells stably transfected with 
glycine transporters (GLYT1 and 2) have shown that relatively high concentrations of 
ethanol (100-200 mM) inhibit uptake of [3H]glycine by GLYT2 and potentiate 
[3H]glycine uptake by GLYT1 (Nunez et al., 2000). Also, acute exposure to ethanol has 
been shown to enhance serotonin transporter (SERT) activity in rat cortical, hippocampal 
and brainstem synaptosomes (Alexi and Azmitia, 1991; Eshleman et al., 1994). 
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High-speed chronoamperometry studies examining the effect of ethanol on 
clearance of locally applied DA in the dorsal striatum of rats suggest that ethanol 
enhances the rate of clearance of DA (Sabeti et al., 2003). Electrochemical studies also 
suggest that ethanol alters DA clearance in vivo (Lin et al., 1993). These results suggest 
that ethanol could alter DAT-mediated DA uptake in vivo. Polymorphisms in DAT gene 
have been linked to alcohol and drug addiction (Hitri et al., 1994; Tiihonen et al., 1995). 
DAT density is altered in human alcoholics experiencing relapse to alcohol abuse 
(Tiihonen et al., 1995). DAT density is increased in ethanol preferring monkeys (Mash et 
al., 1996). Chronic ethanol exposure also produces changes in DAT density in rat striatal 
membranes (Hamdi and Prasad, 1993). In COS-7 cells pre-loaded with DA, ethanol has 
been shown to enhance amphetamine-mediated efflux of [3H] DA (Eshleman et al., 
1994). Acute ethanol (10-100 mM) enhances DAT-mediated [3H]DA uptake and 
transporter-associated currents in a time- and concentration-dependent manner (Mayfield 
et al., 2001). This potentiation of transporter function was accompanied by an increase in 
the number of functional cell surface transporters suggesting that ethanol affects 
transporter function by altering DAT trafficking. 
 
1.8 Research Aims 
 
Electrochemical experiments suggest that local application of ethanol inhibits 
NET function in the rat cerebellar cortex (Lin et al., 1993). Ethanol also inhibits NET 
function in HeLa cells that express NET. Experiments using DAT/NET chimeras and site 
 18
 
directed mutagenesis studies suggest that discrete amino acid residues in the first 
intracellular loop of DAT are important for ethanol regulation of DAT function. The 
absence of consensus sites for PKC or PKA phoshorylation in the first intracellular loop 
suggest that ethanol regulation of DAT function may not be due to increased 
phosphorylation of the protein. Hence, it is hypothesized that ethanol modulates the 
interaction between DAT and a putative regulatory protein important for ethanol-induced 
trafficking of DAT and that this interaction occurs at the first intracellular loop. However, 
not much is known about proteins that interact with DAT. The objective of this study is 
to identify regions on DAT that confer ethanol sensitivity and to delineate the mechanism 
of ethanol action on DAT. The specific aims of this project are as follows. 
 
Aim 1. To characterize DAT function in the ethanol insensitive mutant G130T DAT. 
Preliminary results have shown that the mutations G130T, I137F and L138F in the first 
intracellular loop of DAT render the transporter insensitive to ethanol effects. The 
objective of this aim is to elucidate the kinetics of dopamine uptake in the mutant G130T. 
Also, the first intracellular loop of DAT will be replaced with that of norepinephrine 
transporter (NET) and the effect of ethanol on this mutant will be analyzed. 
 
Aim 2. To determine whether ethanol alters cell surface trafficking of DAT. 
Experiments to address this question will be carried out in mammalian cell lines. GFP-
tagged wild type and G130T DAT will be transfected into mammalian cell lines and 
ethanol-induced trafficking of DAT will be visualized both in real time (using live cells) 
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and in fixed cells by confocal microscopy. Cell surface biotinylation and 
immunofluoresence techniques will also be used to study ethanol-induced changes in 
transporter trafficking in these cells. 
 
Aim 3. To identify novel proteins interacting with the first intracellular loop of DAT.  
Preliminary results have shown that the first intracellular loop of DAT is important for 
ethanol’s enhancement of DAT function. An interaction proteomics based approach will 
be used to investigate proteins that interact differentially with the first intracellular loop 
of DAT. 
 
1.9 Chapter Overview 
 
The second chapter describes the methodologies employed to address the 
questions raised in the specific aims. They include isolation and injection of Xenopus 
oocytes, [3H]DA uptake assays in oocytes and in different cell lines, mass spectrometry 
based proteomics, immunoisolation of DAT-interacting proteins from the striatum etc. 
The third chapter addresses questions raised in Aim 1. Previous studies have 
shown that ethanol enhanced [3H]dopamine  uptake in Xenopus oocytes expressing the 
dopamine transporter (DAT). This increase in DAT activity was mirrored by an increase 
in the number of transporters expressed at the cell surface. In the present study, ethanol 
potentiated the function of DAT expressed in HeLa cells but inhibited the function of the 
related norepinephrine transporter (NET). Chimeras generated between DAT and NET 
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were examined for ethanol sensitivity and demonstrated that a 76 amino acid region 
spanning transmembrane domains (TMD) 2 and 3 was essential for ethanol potentiation 
of DAT function. The first intracellular loop between TMD2 and 3 of DAT, which differs 
from that of NET by four amino acids, was explored for possible sites of ethanol action. 
Site directed mutagenesis was used to replace each of these residues in DAT with the 
corresponding residue in NET and the resulting cRNA’s were expressed in Xenopus 
oocytes. We found that mutations G130T or I137F abolished ethanol potentiation of DAT 
function, whereas the mutations F123Y and L138F had no significant effect. These 
results identify novel sites in the first intracellular loop important for ethanol modulation 
of DAT activity. 
The fourth chapter describes the isolation of proteins associated with DAT and in 
silico analysis of these DAT-associated proteins. Monoamine transporters play a key role 
in neuronal signaling by mediating reuptake of neurotransmitters from the synapse. The 
function of the dopamine transporter (DAT), an important member of this family of 
transporters, is regulated by multiple signaling mechanisms which result in altered cell 
surface trafficking of DAT. Protein-protein interactions are likely critical for this mode of 
transporter regulation. In this study we identified proteins associated with DAT by 
immunoprecipitation followed by mass spectrometry. We identified 19 proteins with 
diverse cellular functions that can be classified into trafficking proteins, cytoskeletal 
proteins, ion channels and extracellular matrix-associated proteins. DAT was found to 
associate with the potassium channel Kv2.1 and synapsin Ib, a protein involved in 
regulating neurotransmitter release. In addition, we have used our proteomics data to 
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query mouse genetic and genomic databases to provide a novel in silico assessment of the 
biological relevance of these interactions. 
Experiments done using the Xenopus expression system suggest that ethanol alters 
DAT function by a mechanism consistent with altered cell surface trafficking of DAT. To 
visualize these trafficking events, ethanol effects on DAT function was examined in 
several different cell lines transiently or stably expressing GFP-tagged DAT. Sindbis 
viral particles expressing GFP-tagged DAT were generated and used to infect neuronal 
cells in culture as well as explants from the VTA. The results of these experiments will 
be summarized in chapter 5. 
The sixth chapter is an overall discussion of the results obtained and conclusions 





















Materials and methods 
 
 




2.1 Transporter chimeras: 
 
Chimeras between the human NET (Pacholczyk et al., 1991) and rat DAT 
(Nelson, 1998) were constructed using a restriction site independent method as 
previously described (Buck and Amara, 1994; Buck and Amara, 1995).  Sequence 
analysis (partial) identified the precise location of each chimera junction and confirmed 
that the junction was in frame. Previous data indicate that most junctions within 
conserved regions of DAT and NET are not disruptive of transporter function (Blakely et 
al., 1991; Fuerst et al., 1987).  
 
 2.2 Substrate uptake in transfected mammalian cells: 
 
           Wildtype and chimeric transporter cDNAs were expressed in HeLa cells 
using the vaccinia/T7 transient expression system as previously described (Blakely et al., 
1991; Fuerst et al., 1987).  This method employed a recombinant vaccinia virus strain 
that encodes a bacteriophage T7 RNA polymerase and allows rapid high-level expression 
of proteins encoded by plasmids bearing T7 promoters (Blakely et al., 1991; Fuerst et al., 
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1987).  Briefly, HeLa cells were plated (2x105cells/well) into 24-well tissue culture 
plates and infected the following day.  The recombinant vaccinia virus strain VTF-7 was 
used to infect cells at 10 plaque-forming units/cell in 100 µl of growth medium. T7 
promoter-driven plasmids with cDNA inserts encoding wildtype NET, DAT or chimeric 
transporters were added 30 min later as liposome suspensions (1 µg DNA and 3 µg 
Lipofectin; GIBCO-BRL) in a total volume of 350 µl /well.  Sixteen hours after 
transfection, the virus/liposome suspension was removed by aspiration, and the cells were 
washed once with 370C KRTH medium containing (in mM): 120 NaCl, 4.7 KCl, 2.2 
CaCl2, 1.2 MgSO4, 1.2 KH2PO4, 5 Tris, 10 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid, pH 7.4.  Cells were preincubated for 1 min at 370C in 500 
µl KRTH in the absence or presence of ethanol (20, 40, 60, or 100 mM).  Uptake was 
initiated by the addition of [3H]DA or [3H]NE (10, 100, or 1000 nM) in KRTH 
containing L-ascorbate (100 µM final).  Uptake was terminated after 20 min at 370C by 
washing twice with 1 ml of ice-cold KRTH medium, cells were solubilized with 0.5N 
NaOH, and the accumulated radioactivity was determined by scintillation spectrometry.  
Nonspecific transport was determined by assays of cells transfected with the plasmid 







2.3 cRNA preparation and oocyte injection:  
 
cDNAs encoding the  human DAT was provided by S.G. Amara and M.S. 
Sonders (Vollum Inst, Oregon Health & Science University, Portland, OR). Capped 
cRNAs were transcribed from linearized plasmids using standard in vitro transcription 
reactions (Stratagene). After manual isolation, Xenopus laevis oocytes were injected with 
water-diluted cRNA (~10 ng/oocyte), and maintained in Frog Ringers Buffer (FRB), 
containing (in mM): 96 KCl, 1.8 CaCl2, 1 MgCl2, and 5 HEPES, pH 7.5 supplemented 
with 2.5 mM Na pyruvate, 0.5 mM theophylline, 100 units/ml penicillin, 100 µg/ml 
streptomycin, and 50 µg/ml gentamycin. Uninjected or water-injected oocytes were used 
to define nonspecific uptake and binding in all experiments. 
 
2.4 Site directed mutagenesis:  
 
Site directed mutagnesis of DAT was performed on cDNA subcloned in pBK-
CMV vector (Stratagene) using the Quick Change Site Directed Mutagenesis Kit 
(Stratagene, La Jolla, CA). Mutagenesis was verified by sequence analysis. 
 
2.5 [3H]DA uptake in Xenopus oocytes: 
 
For [3H]DA uptake assays, DAT expressing oocytes were incubated in 0.5 ml 
FRB containing 100 nM [3H]DA for 10 min at 210C. Oocytes were exposed to 100 mM 
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ethanol (12) for different time periods in tightly sealed 12 well plates.  Oocytes were 
washed three times in FRB and [3H]DA uptake into individual oocytes was quantitated 
by liquid scintillation spectroscopy. 
 
2.6 [3H]WIN 35,428 binding in Xenopus oocytes: 
 
 Whole cell radioligand binding was performed in 0.5 ml FRB containing 4 nM 
[3H]WIN 35,428 for 15 minutes at 40C. Radioactivity was quantitated using liquid 
scintillation spectroscopy. Uninjected oocytes were used to specify non-specific binding. 
Oocyte homogenates were prepared by sonicating 6 DAT (wildtype or mutant) 
expressing oocytes in 0.5 ml ice-cold FRB. Binding to oocyte homogenates was 
performed in 0.5 ml FRB containing 4 nM [3H]WIN 35,428. Non-specific binding was 
determined using 3-PPP (R(+)-3-(3-Hydroxyphenyl)-N-propylpiperidine hydrochloride). 
Binding was terminated by rapid filtration and washing using a vacuum manifold. 
 
2.7 Materials for proteomics: 
 
DBA/2J mice were obtained from Jackson Laboratories (Bar Harbor, Maine). 
DAT (monoclonal) and neurocan antibodies were from Chemicon (Temecula, CA). 
Synapsin, dynamin, NR1 and Brca2 antibodies were from Santa Cruz Biotechnologies 
(Santa Cruz, CA). Kv2.1 antibody was from Sigma (St. Louis, MO). Protein G Plus/ 
Protein A agarose suspension (referred to as agarose beads) was from Oncogene research 
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products (San Diego, CA). HA antibody was from Roche Diagnostics Corporation 
(Indianapolis, IN) 
 
2.8 Co-immunopreciptation of the DAT complex: 
 
Brains obtained from DBA/2J mice (100 days old) were solubilized in ice-cold 
buffer (1% (w/v) sodium deoxycholate, 0.1% (v/v) Triton X-100, and Tris–HCl (500 
mM, pH 9.0) containing protease inhibitors (10 µg/ml of the protease inhibitors 
leupeptin, chymostatin and pepstatin A, Sigma, St. Louis, MO). The homogenate was 
incubated on ice for 1h and insoluble proteins removed by centrifugation at 10,000 x g 
for 10 mins. The soluble protein fraction was dialyzed (Spectrapor MwCO 1200–1400 
Da, Spectrum Laboratories, Rancho Dominguez, CA) against 500 ml 
immunoprecipitation (IP) buffer (50 mM Tris–HCl, pH 7.4, 0.1% Triton X-100). The 
dialysate was centrifuged at 15,000xg for 10 mins and the supernatant used for all IP’s. 
The lysates (supernatant, 2mg protein) were pre-cleared for 2 hrs with protein A/G 
agarose beads (50 µl) and used for IP. IP’s were carried out overnight using 10-25µg of 
DAT antibody. The beads were washed with 60 volumes of IP buffer, and proteins eluted 
by addition of 50 µl Laemmli sample buffer and boiling for 5 mins. IP’s under denaturing 
conditions were carried out by solubilizing the protein in 2% SDS, 2% Triton-X 100 and 
50 mM Tris-HCl, pH 7.5. Solubilized proteins were diluted with five volumes of IP 
buffer prior to incubating with the antibody. For Western Blots samples were separated 
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on 10% SDS PAGE and transferred onto nitrocellulose membranes. Peroxidase 
conjugated secondary antibodies were used for chemiluminiscence detection. 
 
2.9 Crude synaptosome preparation: 
 
Mice striata were dissected into 10 volumes of ice-cold homogenization buffer 
comtaining (in mM) 0.32 Sucrose, 10 HEPES pH 7.4, 2 EDTA. The tissue was 
homogenized using 10-15 strokes of a glass-teflon homogenizer and spun at 1000 x g for 
15 minutes. The supernatant was spun again at 17, 000 x g for 30 minutes and the crude 
membrane pellet was resuspended in HEPES lysis buffer containing 50 mM HEPES, 2 
mM EDTA and protease inhibitors (10 µg/ml of the protease inhibitors leupeptin, 
chymostatin and pepstatin A, Sigma, St. Louis, MO).  
 
2.10 Preparation of protein samples:  
 
DAT-associated proteins were separated by 10% SDS-PAGE and the bands were 
visualized by coomassie staining. Individual bands ranging from 30 kDa-300 kDa were 







2.11 Mass Spectrometry:   
 
Experiments were performed using a microcapillary LC system (Agilent 1100 
series) on-line with an Esquire ion trap mass spectrometer (Bruker Instruments). Peptides 
were separated using a 30 x 0.15 mm C18 column and a short linear gradient; 2-65% 
buffer B (0.1 % formic acid, 0.01% trifluoroacetic acid in 10% HPLC grade water, 12% 
isopropyl alcohol and 68% acetonitrile) in 5 mins at a flow rate of 2 µl/min. All peptides 
were eluted off the column within 35 minutes. For optimal results, up to 9 precursor ions 
were automatically selected for fragmentation. A list of the masses containing precursor 
ion and fragmentation data was generated and used for database searches. 
 
2.12 Strategy for Protein Identification:  
  
Protein identifications were performed using the search engine MASCOT (45). A 
non-redundant database was searched without applying any constraint on molecular 
weight. Proteins were identified based on at least 2 peptide matches and were classified 
into high and medium probability hits using the following criteria: high probability hits 
were proteins identified by MASCOT as having a high probability based Molecular 
Weight Search (MOWSE) score (Perkins et al., 1999). Medium probability hits were 
proteins with a low probability based MOWSE scores, but were reliably 
immunoprecipitated in multiple experiments and for which good fragmentation patterns 
were detected (Husi et al., 2000).  
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2.13 In silico analysis of DAT transcriptome: 
 
 To evaluate the relevance of the identified proteins, we investigated their 
relationships at the transcriptional level using data from a public web-based database (the 
WebQTL Project, www.webqtl.org). This database contains mRNA abundance values for 
over 12,000 genetic transcripts measured by Affymetrix® microarrays in 32 BXD 
recombinant inbred (RI) strains, their progenitor strains – C57BL/6J (B) and DBA/2J (D), 
and the BXD F1 hybrids. In addition to transcriptome information, WebQTL contains 
published data on hundreds of phenotypical traits studied in some of the BXD RI. 
 Forebrain mRNA abundance values for DAT proteome genes were extracted from 
UTHSC Brain mRNA U74Av2 (Dec03) MAS5 database (see 
http://webqtl.org/dbdoc/U74Av2Mas5_December03.html for sample preparation details). 
To investigate gene expression patterns principal component analysis (PCA) was carried 
out using STATISTICA package (Version 6.1, StatSoft, Inc). WebQTL databases were 
also used to obtain Pearson’s product moment correlations between several published 
BXD phenotypes functionally related to DAT and expression values of the DAT 
proteome genes. 
 
2.14 Generation of Sindbis viral constructs encoding GFP-DAT: 
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The hDAT-EGFP cDNA containing EGFP fused to the carboxyl terminus of DAT 
was excised from the plasmid hDAT- pEGFP (3) at the Kpn1-Xba1 sites and inserted into 
the Pml1 site of the plasmid pSINREP5 (Invitrogen, CA). In vitro transcription of the 
 
resulting construct and that of the helper virus construct DH(26S)5’SIN was carried out 
using SP6 polymerase (mMessage mMachine Kit, Ambion, Austin, TX). 
 
 
2.15 [3H]DA uptake in BHK cells and MDCK cells expressing GFP-DAT: 
 
 
BHK cells were grown to confluence on 12-well dishes and infected with 
pseudovirions. The cells were assayed 12-18 hours post infection. Uptake was initiated 
by the addition of 100 nM [3H]DA (NEN life science products) and allowed to proceed 
for 10 min at room temperature. Nonspecific uptake was determined in uninfected cells 
and in cells treated with 3-PPP (R(+)-3-(3-Hydroxyphenyl)-N-propylpiperidine 
hydrochloride). 
 
2.16 Preparation and infection of explant cultures with virions: 
 
Mesolimbic explants were obtained from Sprague-Dawley pups. Slices containing 
the VTA/NAc were placed in 30 mm Millipore CM membrane inserts housed in six well 
plates with 1.2 ml per well of HEPES-buffered  75% MEM, 25% horse serum, 3 mM L-
Glutamine, 100 units/ml penicillin/streptomycin and 5.5 mg/ml dextrose and incubated in 
5% CO2 at 370C. Explants were infected following the basic methods as described (4). 
Concentrated virus was injected manually using a micromanipulator at 3-5 sites/slice via 
borosilicate glass pipette electrode broken to about 20 µm diameter. Approximately 50 nl 
was injected into each site. 
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2.17 Preparation and infection of midbrain DA neurons in culture: 
 
Primary neuronal cultures from the midbrain were made from Sprague-Dawley 
pups (1-3 days old) under IACUC guidelines. Dissociated neurons were plated onto 
chambered coverglasses (Fisher Scientific). The culture medium (Neurobasal media, 1x 
B-27, 100 Units/ml Pen Strep, Amphotericin B) was serum-free and contained 
Neurobasal-A supplemented with B-27 to maintain pure populations of neuronal cells. 
Medium was changed every 3 days. Cells were imaged 24 hours after infection with 
sindbis viral particles (40 µl of unpurified GFP-DAT). Media was replaced with aCSF (in 
Mm: 120, NaCl;  3.3 KCl; NaH2PO4, 1.23; NaHCO3, 25; CaCl2, 2.0; MgSO4, 0.9; 
dextrose, 10; continuously gassed with 95% O2/ 5% CO2, Ph 7.2). 
 
2.18 Fluorescence Imaging: 
 
BHK cells and cultured neuronal cells were grown in chambered coverglass or 3.5 
mm petridishes and imaged using an Olympus IX-70 microscope. GFP-fluorescence in 
explants was induced by two-photon excitation using a mode-locked Spectra-Physics 
Tsunami titanium:sapphire laser pumped by a millenia 5.5W argon source. Scans were 







2.19 Generation of stably transfected cell lines:  
 
 
NG108, SKNSH, and SH-SY5Y cells were obtained from ATCC (Va). The cells 
were grown to 80% confluence in media (recommended by ATCC) containing 10% FBS. 
The cells were transfected using 1.5ug of GFP-tagged wildtype and G130T DAT cDNA. 
Five hours after transfection the cationic lipid-containing media was replaced with 
medium containing 10% FBS. 48 hours post-transfection the media was replaced with 
media containing .25 (SH-SY5Y)-0.5mg/ml (NG108 AND SKNSH) G418 (Invitrogen, 
CA). Selection in the presence of G418 was carried out for 2-3 weeks after which 




























Ethanol modulation of the human dopamine transporter function∗ 
 
3. 1 Introduction 
 
The family of Na+ and Cl- dependent transporters, which include the dopamine 
(DA) 1 and norepinephrine (NE) transporters (DAT and NET, respectively), function to 
clear released neurotransmitters from the synaptic cleft (Nelson, 1998). DAT regulates 
the spatial and temporal aspects of dopaminergic synaptic transmission and is an integral 
part of the mesostriatal DA system. This system plays a central role in mediating the 
rewarding and reinforcing effects of various drugs of abuse including ethanol (Brodie and 
Appel, 1998; Brodie et al., 1990; Weiss et al., 1993). DAT is also the site of action for 
various psychostimulants like cocaine and amphetamine (Nelson, 1998). The function of 
monoamine transporters at the cell membrane is regulated by multiple second messenger 
systems, and this regulation involves redistribution of the transporters at the cell surface 
rather than changes in rate of flux of substrate. For example, activation of protein kinase 
C (PKC) and drugs of abuse like amphetamine inhibit DAT function by causing 
internalization of cell surface transporters in a dynamin- and clathrin-dependent manner 
(Daniels and Amara, 1999; Melikian and Buckley, 1999; Saunders et al., 2000). 
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Experiments carried out in human embryonic kidney (HEK-293) cells demonstrated that 
acute exposure to cocaine enhances DAT activity in a time-dependent manner by 
increasing the number of functional transporters at the cell surface (Daws et al., 2002). 
Cocaine also increases the number of DAT binding sites in neuro2A (N2A, derived from 
mouse neuroblastoma) cells by altering the intracellular trafficking of DAT (Little et al., 
2002). 
Ethanol has been shown to affect the function of several members of the Na+ and 
Cl- dependent family of transporters. Experiments in HEK-293 cells stably transfected 
with glycine transporters (GLYT1 and 2) have shown that relatively high concentrations 
of ethanol (100-200 mM) inhibit uptake of [3H]glycine by GLYT2 and potentiate 
[3H]glycine uptake by GLYT1 (Nunez et al., 2000). Also, acute exposure to ethanol has 
been shown to enhance serotonin transporter activity in rat cortical, hippocampal and 
brainstem synaptosomes (Alexi and Azmitia, 1991). Acute ethanol (10-100 mM) 
enhances DAT-mediated [3H]DA uptake and transporter-associated currents in a time- 
and concentration-dependent manner (Mayfield et al., 2001). This potentiation of 
transporter function was accompanied by an increase in the number of functional cell 
surface transporters suggesting that ethanol affects transporter function by altering the 
steady state trafficking of DAT to the cell surface. In contrast, electrochemical 
experiments suggest that NET function is inhibited by ethanol (Lin et al., 1993). 
DAT shares a high degree of sequence homology with NET but results outlined 
above suggest that ethanol may have different effects on DAT and NET function. In the 
present study, we use the contrasting effects of ethanol on DAT and NET function to 
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identify critical amino acids in DAT that are important for ethanol action. DAT/NET 
chimeras were expressed in HeLa cells to identify discrete structural domains on DAT 
and NET that are important for ethanol regulation of transporter function. Site directed 
mutagenesis experiments were then carried out and mutant transporters were functionally 
analyzed to pinpoint individual amino acid residues that may be crucial for ethanol 
enhancement of DAT function. 
 
3.2 Effect of ethanol on wildtype DAT and NET expressed in HeLa cells:  
 
Wildtype DAT and NET were expressed in HeLa cells and the effect of ethanol 
on [3H]DA and [3H]NE accumulation into these cells was measured. In DAT expressing 
cells, ethanol (20-100mM) significantly increased [3H]DA uptake in a concentration-
dependent manner, with 60 mM ethanol producing an ~50% increase in DA uptake 
(Figure 2a). In contrast, in NET expressing cells, ethanol (40-100mM) inhibited [3H]NE 
uptake by as much as 22% (Figure 2b) but had no effect on NET mediated [3H]DA 
uptake (Table 1). 
 
3.3 Structural domains essential for ethanol potentiation of DAT function:  
 
DAT and NET chimeras were generated and eight chimeras (i.e. four sets of 
approximately reciprocal chimeras) having junctions in or near transmembrane domains 
(TMD) 1, 3, 9, and 10 were used in this study (Figure 2). The chimeras were referred to 
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as NET/DAT or DAT/NET according to their relative orientations and are numbered to 
indicate a TMD near their junction. Maximally effective concentrations of ethanol (40-
100 mM) were chosen for each chimera. DA uptake was similar to that observed for 
wildtype transporters (Vmax > 90% of wildtype DAT) in most of the chimeras used in 
this study. However, chimeras NET/DAT3, DAT/NET1, and DAT/NET3 showed DA 
uptake that was 60-80% of that observed for wildtype DAT (16, 17). 
Functional analyses of the chimeric transporters indicate that chimeras that 
possess DAT sequence elements within the region including TMD 1-3 all demonstrate 
enhancement of [3H]DA uptake by ethanol as did DAT (Table 1). In contrast, in chimeras 
with sequence elements within TMD 1-3 from NET, [3H]DA uptake was not enhanced by 
ethanol, and thus   resembled NET in this regard. These results indicate that ethanol 
enhancement of DAT function requires the TMD 1-3 region of DAT. Chimeras 
NET/DAT1 and DAT/NET1 with junctions in TMD1 (F78 and W63, respectively) were 
also tested for ethanol effects. Ethanol responsiveness of these two chimeras was similar 
to DAT and NET respectively (Table 1). Furthermore, we also tested chimeras 
DAT/NET9, DAT/NET10, NET/DAT10, and NET/DAT11 with junctions downstream of 
TMD3 (TMD9, TMD10, and TMD11 respectively), for ethanol effects. These chimeras 
demonstrated ethanol sensitivities comparable to that of NET/DAT3 and DAT/NET3, 








Figure 2: Schematic representation of wildtype (A) and chimeric (B) DAT and NET.  
Approximately reciprocal chimeras made from combinations of NET (black) and DAT 
(white) are shown. Each chimera is designated as DAT/NET or NET/DAT to identify 
orientation and numbered to indicate the TMD nearest its junction. These chimeras depict 





Figure 3:  Ethanol effects on [3H]DA uptake  and [3H]NE uptake in HeLa cells 
expressing wildtype DAT and NET, respectively. Cells were preincubated for 1 minute at 
370C with different concentrations of ethanol. Uptake was initiated by the addition of 
10nM [3H]DA or [3H]NE for 20 minutes. (A) Ethanol potentiated [3H]DA uptake in DAT 
expressing HeLa cells. Maximum potentiation (50%) was observed with 60mM ethanol. 
(B) [3H]NE uptake was dose-dependently inhibited by ethanol. Maximum inhibition 
(22%) was observed in the presence of 100mM ethanol. Mean values +SEM are shown 













Table 1:  Effect of ethanol on [3H]DA uptake in HeLa cells expressing wildtype DAT, 
NET and chimeric transporters 
Maximal effective concentrations of ethanol (40-100 mM) were chosen for each chimera. 
Uptake was initiated by the addition of 10nM [3H]DA for 20 minutes. *p<.05 as 




Enhancement of DA 
uptake by ethanol: 
% of control 
Km DA (µM) Km NE (µM) 
WT DAT 178+19* 3.0 5.0 
WT NET 103+5 0.2 0.4 
ND1 147+15* 3.0 3.0 
DN1 99+5 0.2 0.4 
ND3 101+7 0.8 1.7 
DN3 143+16* 1.0 2.0 
ND10 112+20 0.6 0.9 
DN9 172+25* 2.0 2.0 
ND11 116+21 0.3 0.4 




3.4 Site directed mutagenesis of DAT:  
 
Mutagenesis studies were carried out in human DAT to pinpoint sites of ethanol 
action within the TMD 1-3 region. Since intracellular loops are more accessible for 
proteins that modulate trafficking (20), we explored the intracellular loop between TMD 
2 and TMD 3 for possible sites of ethanol action. The first intracellular loop differs 
between DAT and NET by only four amino acids at positions 123, 130, 137, and 138. 
Each of these amino acids in DAT was replaced with the corresponding amino acid from 
NET. The resulting cDNAs were transcribed in vitro and expressed in Xenopus oocytes.   
Oocytes expressing wildtype and G130T mutant DAT were exposed to ethanol 
for 1 or 4 hours and [3H]DA uptake was measured. The time periods were chosen to 
examine the effects of ethanol on [3H]DA uptake as a function of ethanol exposure time. 
Basal [3H]DA uptake in this mutant was 1.2 fmol/sec/oocyte which was comparable to 
that of wildtype DA uptake (1.0 fmol/sec/oocyte).  Wildtype DAT expressing oocytes 
showed a 50% potentiation of [3H]DA uptake after 4 hours of ethanol exposure. In 
contrast, the potentiating effects of ethanol were abolished in the G130T DAT mutant 









Figure 4:  Ethanol had no effect on [3H]DA uptake in G130T DAT. [3H]DA  (100nM) 
uptake was measured in wildtype (WT) and G130T DAT expressing oocytes after a 4 
hour exposure to either ND96 (white bar) or 100 mM ethanol (black bar). Ethanol 
potentiated [3H]DA uptake (~ 50%) after 4 hours of exposure, in wildtype DAT 
expressing oocytes. In contrast, ethanol potentiation of DAT activity was not observed in 
the G130T DAT mutant. Mean values + SEM are shown for n=6-10 oocytes per 
condition from 3-4 batches of oocytes. *p<0.05 as compared to ethanol potentiation of 










Amino acids phenylalanine at position 123, isoleucine at position 137, and leucine 
at position 138 were also mutated to the corresponding amino acids in NET (F123Y, 
I137F, and L138F, respectively). [3H]DA uptake in these mutants was comparable to that 
of wildtype DAT  (data not shown). Maximum potentiation of transporter function was 
observed after 1 hour of ethanol exposure in oocytes expressing wildtype transporter 
(Figure 5). After exposure to 100 mM ethanol for 1 hour, potentiation of  [3H]DA uptake 
was not observed in the mutant I137F (Figure 4). The mutant F123Y showed ethanol 
sensitivity comparable to that of wildtype DAT (Figure 4). Ethanol sensitivity of the 
mutant L138F was reduced but not significantly as compared to that of wildtype DAT 
(Figure 5). 
Previously, we showed that ethanol potentiation of DAT activity was mirrored by 
an increase in the density of cell surface transporters (12). Upon exposure to ethanol for 1 
and 4 hours [3H]WIN 35,428 binding was significantly increased by 40% and 53% 
respectively (12). We investigated cell surface transporter numbers in the mutant G130T 
DAT in the presence and absence of ethanol by measuring [3H]WIN 35,428 binding. 
G130T DAT cell surface density was approximately 20 fmol/oocyte. Ethanol had no 










Figure 5: Effects of ethanol on F123Y, I137F, and L138F mutants. [3H]DA uptake was 
measured in oocytes expressing wildtype versus mutant DAT. Oocytes expressing WT 
and mutant transporters were exposed to 100 mM ethanol for 1 hour and [3H]DA (100 
nM) uptake was measured. Enhancement of [3H]DA uptake was observed in wildtype 
(white bar) and F123Y (black bar) expressing oocytes, but not in the mutants I137F and 
L138F. Mean values + SEM are shown for n=8-10 oocytes per condition from 4-5 




Figure 6:  Ethanol does not change [3H]WIN 35,428 binding in G130T expressing 
oocytes. [3H]WIN 35,428 (4nM) binding was measured in oocytes expressing G130T 
DAT in the absence (0 hr) and presence of ethanol (1-4hr). [3H]WIN 35,428 binding in 
oocytes exposed to ethanol (black bars) did not differ significantly from untreated 
controls (white bars). Mean values + SEM are shown for n=6-10 oocytes per condition 












To test whether ethanol inhibits DAT function when the first intracellular loop is 
replaced with that of NET, we substituted the first intracellular loop of DAT with that of 
NET (by sequentially mutating positions F123, G130, I137 and L138 to the 
corresponding amino acids in NET). This loop replacement mutant is termed IGLF. 
[3H]DA uptake and [3H] WIN 35,428 binding was measured in this mutant and compared 
to wildtype. [3H]DA uptake was not observed in the mutant IGLF (Figure 7A). [3H]WIN 
35,428 binding in the mutant IGLF was significantly reduced as compared to that of 
wildtype DAT (Figure 7B). We next carried out [3H]WIN 35,428 binding studies on 
oocyte homogenates (Methods). We found that the mutant IGLF is synthesized but not 
















Figure 7: The mutant IGLF is expressed but not trafficked to the cell surface. [3H]DA 
uptake and [3H]WIN 35,428 binding studies were carried out in the quadruple DAT 
mutant IGLF. (A) [3H]DA uptake was not observed in oocytes expressing the transporter 
IGLF . (B) Cell surface transporters were measured in oocytes expressing both wildtype 
and mutant transporters using 4nM [3H]WIN 35,428. (C) Binding was not detected in the 
mutant IGLF. Homogenates of oocytes expressing wildtype and IGLF transporters 
assayed for [3H]WIN 35,428 binding . Similar levels of binding were detected in both 
wildtype and mutant expressing oocytes. Mean values + SEM are shown for n=6 oocytes 
per condition from 3-4 batches of oocytes. * p<0.05, **p<0.005 as compared to 














Previous studies carried out in the Xenopus oocyte expression system have shown 
that acute ethanol (10-100mM) enhances [3H]DA uptake and transporter-associated 
currents in a time- and concentration-dependent manner. Ethanol-induced increases in 
cell surface DAT were not associated with increased protein synthesis (Mayfield et al., 
2001), but were associated with increased cell surface binding. These results suggest that 
ethanol enhancement of transporter function may involve redistribution of DAT at the 
cell surface. The goal of this study was to determine regions on DAT that are critical for 
ethanol action. NET, which also belongs to the Na+ and Cl- dependent family of 
neurotransmitter transporters, shares a high degree of homology (64%) with DAT 
(Mayfield et al., 2001); but, in vivo electrochemical studies have shown that ethanol 
inhibits rather than enhances NET function (Lin et al., 1993).  
We used chimeras between DAT and NET and site directed mutagenesis studies 
to define critical ethanol sensitive sites in the first intracellular loop of the transporter. 
The kinetic parameters of DA uptake (Km and Vmax) in most of these chimeras were 
nearly identical to wildtype DAT. These chimeras showed that ethanol enhancement of 
DAT-mediated [3H]DA uptake  required the presence of TMD 1-3. Replacing this region 
of DAT with the corresponding region from NET resulted in abolition of ethanol effects. 
Chimeras NET/DAT1 and DAT/NET1 with junctions in TMD1 had ethanol sensitivities 
comparable to DAT and NET, respectively. In contrast, chimeras NET/DAT3 and 
DAT/NET3 with junctions at TMD3 have ethanol sensitivities comparable to NET and 
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DAT. Also, chimeras with junctions downstream of TMD3 (NET/DAT10 and 11, 
DAT/NET9 and 10) resemble NET/DAT3 and DAT/NET3 in their ethanol sensitivities. 
Taken together, these results indicate that a 76 amino acid region spanning TMD 1-3, 
including the first intracellular loop, is critical for mediating ethanol enhancement of 
DAT function.  
Since intracellular loops are accessible at all times to modifying enzymes and 
accessory proteins that modulate trafficking (Quick et al., 1997), we explored the first 
intracellular loop between TMD2 and TMD3 for possible sites of ethanol action. This 
loop in DAT differs from that of NET by four amino acids. Site directed mutagenesis was 
carried out to substitute glycine at position 130 to threonine, the corresponding amino 
acid in NET. [3H]DA uptake in this mutant was comparable to that of the wildtype DAT, 
however, ethanol potentiation of [3H]DA uptake was abolished completely in this mutant. 
Using [3H]WIN 35,428 binding, we examined cell surface expression of this mutant 
before and after ethanol exposure. [3H]WIN 35,428 binding to the wildtype DAT is Na+-
dependent and low intracellular concentrations of sodium ions in the oocyte prevent 
[3H]WIN 35,428  from binding to intracellular DAT (Barish, 1983; Reith and Coffey, 
1993). Ethanol had no effect on the number of cell surface G130T mutant transporters 
indicating that this amino acid is critical for ethanol-mediated increases in [3H]DA 
uptake. This suggests that ethanol affects DAT function by altering cell surface 
distribution of the transporters.  
We also mutated amino acids F123, I137 and L138 to the corresponding amino 
acids in NET. We found that I137F abolished ethanol potentiation of [3H]DA uptake, 
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whereas the other mutations demonstrated ethanol sensitivities comparable to the 
wildtype DAT. Robust changes in ethanol sensitivities were observed in the mutant 
G130T and I137F, which are nonconservative amino acid changes and no change in 
ethanol sensitivity was observed in the F123Y mutant, which is a conservative amino 
acid change. However, the mutant L138F did not demonstrate significant attenuation of 
ethanol sensitivity despite being a nonconservative mutation. We generated the mutant 
transporter IGLF to investigate whether replacing the first intracellular loop of DAT with 
that of NET would result in ethanol inhibition of [3H]DA uptake. However, this mutant 
transporter does not demonstrate [3H]DA uptake and expresses a significantly lower 
number of functional transporters at the cell surface. Oocyte fractionation studies indicate 
that the transporters are synthesized but not trafficked to the cell surface. This result, 
though unexpected, supports the hypothesis that the first intracellular loop is important 
for steady state insertion of DAT to the cell surface. 
There is now an emerging literature on mutations that affect ethanol actions on 
ion channels and it is of interest to compare our analysis of catecholamine transporters 
with studies of other proteins. Discrete amino acid residues located either in TMD or in 
the cytoplasmic regions are required for ethanol action on ion channels (Harris, 1999). 
For example, mutation of serine 267 at TMD2 of the glycine receptor (GlyR) α1 subunit 
to isoleucine results in an alcohol insensitive receptor (Mihic et al., 1997). A 
transmembrane phenylalanine residue is important for ethanol inhibition of N-methyl-D-
aspartate receptors (Ronald et al., 2001). Alcohol modulation of G-protein coupled 
inwardly rectifying potassium channel (GIRK) function requires a 48 amino acid region 
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in the intracellular C-terminal region of the protein (Lewohl et al., 1999). Similarly, 
ethanol action on voltage sensitive potassium channels (Kv1) requires the presence of a 
discrete amino acid residue in the putative cytoplasmic region of the protein (Covarrubias 
et al., 1995). Ethanol affects the function of metabotrophic glutamate receptors (mGluR1) 
indirectly by enhancing PKC-mediated receptor phosphorylation (Minami et al., 1998).  
Mutation of a consensus PKC phosphrylation site, serine 890, abolishes ethanol 
regulation of receptor function. None of these sites appear to be important for protein 
trafficking; in contrast, our results identify novel amino acid residues in the first 
intracellular loop of DAT that are necessary for ethanol modulation of DAT function by a 
mechanism that is consistent with altered trafficking of the protein to the cell surface. 
 A common theme in the functional regulation of the Na+/Cl--dependent family of 
transporters is the redistribution of cell surface transporters.  Several agonists and 
antagonists of gamma-aminobutyric acid and serotonin transporters have been shown to 
alter subcellular distribution of these transporters (Whitworth et al., 2002; Whitworth and 
Quick, 2001). PKC activators like PMA downregulate DAT function by causing 
internalization of cell surface DAT (Daniels and Amara, 1999; Melikian and Buckley, 
1999; Zhu et al., 1997). Protein tyrosine kinase A (PKA) inhibitors have been shown to 
inhibit DAT function by internalization of cell surface DAT (Doolen and Zahniser, 
2001). Drugs of abuse have also been shown to alter cell surface DAT densities in some 
but not all studies. For example, amphetamine decreases cell surface DAT levels by 
endocytosing the transporter in a dynamin- and clathrin-dependent manner in HEK-293 
cells (Saunders et al., 2000).  More recently two independent studies have shown that 
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cocaine causes an increase in the cell surface DAT levels (Daws et al., 2002; Little et al., 
2002).These studies, carried out in N2A cells and HEK-293 cells demonstrate that 
cocaine-induced enhancement in cell surface DAT levels is due to increased rates of 
insertion of DAT at the cell surface. Also, dopamine D2 receptor activation affects DAT 
function by increasing the number of functional cell surface transporters (Mayfield and 
Zahniser, 2001). Our results, which suggest that ethanol-mediated functional regulation 
of DAT involves redistribution of cell surface transporters and that this redistribution 
involves discrete regions on the transporter, fits very well with this common theme in 
transporter regulation. 
 The absence of consensus sites for PKC or PKA phoshphorylation in the first 
intracellular loop suggests that ethanol regulation of DAT function may not be due to 
increased phosphorylation of the protein. Furthermore, it has been demonstrated that 
direct phosphorylation of the transporter is not required for functional regulation by PKC 
(Chang et al., 2001). It is likely that accessory proteins aid in the functional regulation of 
DAT, but these remain largely unknown. Recent studies using yeast two-hybrid 
techniques have identified candidate proteins that interact with the C-terminal tail of 
DAT and regulate transporter function. For example, α-Synuclein interacts with DAT in 
neurons and the resulting DAT-α-synuclein complex has been shown to be essential for 
clustering of DAT at the cell surface and thereby accelerating cellular DA uptake and 
DA-induced apoptosis (Lee et al., 2001). The C-terminal tail of DAT also contains a 
conserved PDZ domain that interacts with the protein PICK1 and this interaction is 
crucial for proper targeting and functioning of DAT (Torres et al., 2001). Based on our 
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mutants, we hypothesize that ethanol modulates the interaction between DAT and a 
putative regulatory protein important for ethanol-induced trafficking of DAT and that this 
interaction occurs at the first intracellular loop. The ethanol insensitive mutants described 








































Defining the Dopamine Transporter Proteome by Convergent Biochemical and In 
Silico Analyses∗ 
4.1 Introduction 
Monoamine transporters modulate neurotransmission in the brain by mediating 
reuptake of released neurotransmitter from the extracellular space. This family of proteins 
includes the serotonin (SERT), norepinephrine (NET), and dopamine transporter (DAT)1. 
DAT, which is responsible for removing released dopamine from extracellular space, is a 
particularly important site of action for the clinical effectiveness of drugs used to treat 
attention defecit hyperactivity disorder (Volkow et al., 2002). In addition, inhibition of 
DAT function is also highly correlated with the abuse potential of drugs like cocaine and 
amphetamine (Gainetdinov et al., 2002).  
DAT is an integral part of the brain reward pathway and is abundantly expressed 
exclusively in dopaminergic neurons. DAT is localized to distal dendrites and 
perisynaptic terminals of dopaminergic cells in the substantia nigra and striatum 
respectively (Nirenberg et al., 1997a). DAT function at the cell surface is regulated by 
second messenger systems, which can alter the subcellular distribution of the transporter. 
Drugs of abuse such as amphetamine have been shown to down regulate transporter 
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function by a dynamin- and clathrin-dependent mechanism (Zahniser and Doolen, 2001). 
In contrast to inhibition of DAT function by amphetamine, cocaine and ethanol enhance 
DAT function by a mechanism consistent with altered cellular trafficking of DAT (Maiya 
et al., 2002; Mayfield et al., 2001; Zahniser and Doolen, 2001). Regulated DAT 
trafficking would require the transporter to interact with specific proteins involved in cell 
surface targeting. However, little is known about proteins that interact with and regulate 
DAT function. The DAT sequence possesses several consensus sites for protein-protein 
interactions, including a PDZ binding domain at the C-terminus (Torres et al., 2001). 
Currently, three proteins have been identified that alter DAT function by interacting 
directly with the transporter. These proteins were identified by the yeast two-hybrid 
approach using the C-terminal tail of DAT as bait. These are α-synuclein (Lee et al., 
2001), the PDZ domain containing protein PICK1 (protein interacting with C kinase 1, 
7), and Hic-5 (hydrogen peroxide-inducible protein 5, (Carneiro et al., 2002)).  
An emerging theme in neuronal cell signaling is the assembly of receptors and 
channels into large macromolecular complexes via protein-protein interactions. For 
example, 77 proteins involved in mediating a variety of cellular functions have been 
found to associate with the NMDA receptor (Husi et al., 2000). The goal of this study 
was to identify proteins that exist in a complex with DAT using an interaction-proteomics 






4.2 Isolation and validation of the DAT proteome 
 
The DAT proteome was isolated from mouse striatum by IP (Figure 8A, 8B). A 
band (approximately 70-80 kDa) corresponding to DAT was readily detected by mass 
spectrometry. Numerous bands were detected in the DAT complex when compared to 
proteins that were immunoprecipitated using a monoclonal anti-HA (haemagglutinin) 
antibody (Figure 8B). The IP procedure was validated by examining the association 
between DAT and α-synuclein, which was readily detected in the DAT complex isolated 
from the striatum but not the cerebellum (Figure 8C). The DAT antibody did not 
immunoprecipitate the NMDA receptor subunit, NR1 (Figure 8D) suggesting that the 































































Figure 8: Co-immunoprecipitation of DAT-associated proteins. A) DAT-associated 
proteins were immunoprecipitated from the striata of male DBA/2J mice and the proteins 
were separated using SDS-PAGE (10%) and visualized with coomassie staining. B) 
Nonspecific immunoprecipitation of proteins using same amount of protein as in (A) 
using monoclonal HA antibody. C) DAT-associated proteins were immunoprecipitated 
from the striatum and the blot was probed for α-synuclein (n=2). D) IP using DAT 
antibody and Western Blot using anti-NR1 antibody. Str-Striatum IP, Cer-Cerebellum IP 
(negative control), Str Lys-Striatal Lysate (positive control). Small arrows indicate 
approximate positions of bands excised and large arrows indicate IgG heavy and light 
chains. 
 
4.3 Mass Spectrometry: 
 
 Approximately 20-25 bands ranging from 35 to 300 kDa were excised from the 
coomassie-stained gel and the proteins identified by LC-ESI-MS. 20 Candidate proteins 
were identified and classified as high and medium probability hits (Methods, Table 2).  



















Table 2: Classification of high- and medium-probability proteins. 
Proteins were grouped according to known cellular function. Proteins were classified into 
high and medium probability (italics) hits as described. Fragmentation patterns and 
sequence information were analyzed for medium probability hits. The maximum numbers 
of peptides detected for each protein are reported. 






Ras GRF2 (P70392) 




















Similar to Mitochondrial aconitase (Q99KI0) 
Fructose bis phosphate aldolase (ADMSA) 






Cell Adhesion molecules 
Neurocan (S52781) 




Synapsin I (AAD08933) 
Dynamin I (Q61358) 
Synaptojanin 2(AAC40153) 
Adapter protein 1 beta (Q922E2) 
 
on Channels 
KV 4.3M (AAD16974) 
KV 2.1 (I56529) 



















   Miscellaneous 
  Par-3 (Q99NH2)                                                                                                2 





4.4 Confirmation of members of the DAT proteome: 
 
Eight peptides corresponding to synapsin 1b were detected by mass spectrometry 
(Table 1). To confirm the presence of synapsin Ib in the DAT complex, co-
immunoprecipitation experiments were carried out using DAT and synapsin I (both a and 
b) antibodies under non-denaturing and denaturing conditions. Under non-denaturing 
conditions, DAT antibody could immunoprecipitate synapsin from the striatum (Figure 
9B). Only a faint band could be detected in the cerebellum, a region devoid of DAT. 
Synapsin antibody could also IP DAT from the striatum (Figure 9A). DAT was not 
immunoprecipitated by an antibody directed against the NMDA receptor subunit, NR1 
(Figure 9H). Association between DAT and synapsin was disrupted when IP’s were 
performed under denaturing conditions, thereby ruling out non-specific association of 
synapsin with the protein A/G agarose or antibody used for IP (data not shown). Slightly 
lower amounts of DAT were immunoprecipitated under denaturing conditions when 
compared to immunoprecipitations under non-denaturing conditions (data not shown). 
The presence of dynamin in the DAT complex was also similarly confirmed using DAT 
and dynamin antibodies (Figure 9C, 9D). These interactions were also disrupted under 
denaturing conditions (data not shown). Synapsin and dynamin were also 
immunoprecipitated by a polyclonal antibody directed against DAT (data not shown). 
Four peptides corresponding to Kv2.1, a potassium channel, were detected in two 
out of four experiments; hence Kv2.1 was classified as a medium probability hit. Kv2.1 
antibody was used to IP Kv2.1-associated proteins from the striatum and the blot was 
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probed with DAT antibody (Figure 9E). A band corresponding to DAT was observed in 
the striatum but not in the cerebellum. Association between DAT and Kv2.1 was not 
observed under denaturing conditions (data not shown). The presence of Brca2 and 
neurocan was also confirmed by Western Blots using Brca2 and neurocan antibodies. 
DAT was immunoprecipitated under non-denaturing conditions using the Brca2 and 
neurocan antibodies (Figure 9F, 9G). This interaction was disrupted under denaturing 
conditions (data not shown). We were not able to unambiguously detect the presence or 
absence of Kv2.1, Neurocan or Brca2 by immunoprecipitating DAT using the 
monoclonal DAT antibody followed by Western Blots using antibodies directed against 
these candidate interactors. 
The subcellular localization of Kv2.1 has not been examined in the striatum. 
Crude synaptosomal membranes were prepared and examined for the presence of Kv2.1 
and DAT, to verify that Kv2.1 was localized to the same cellular compartment as DAT. 
As illustrated in Figure 3, Kv2.1 (top panel) is enriched in synaptosomes as DAT (middle 















































































Figure 9: IP under non-denaturing conditions followed by Western Blots was performed 
to confirm the presence of candidate proteins in the DAT complex. A) IP with synapsin 
and Western Blot using DAT antibody B) IP with DAT antibody and Western Blot using 
synapsin antibody C) IP with dynamin antibody and Western Blot with DAT antibody D) 
IP with DAT antibody and Western Blot using dynamin antibody E) IP with Kv2.1 
antibody and Western Blot with DAT antibody F) IP with Brca2 antibody and Western 
Blot with anti DAT antibody G) IP using anti neurocan antibody and Western Blot using 
anti DAT antibody. H) IP with anti-NR1 antibody and Western Blot using anti-DAT 
antibody. Str-Striatum IP, Cer-Cerebellum IP; negative control, Str Lysate-Striatal 
Lysate; positive control. Equal amounts of cerebellar and striatal lysates were used for 
each immunoprecipitation. All of the images depicted for a particular protein were 

















Figure 10: Enrichment of Kv2.1 in the synaptosomal fraction. Equal amounts of (60 µg) 
striatal homogenate and synaptosomal preparation were loaded on a gel and probed for 
the presence of Kv2.1 and DAT. Both Kv2.1 and DAT were enriched in the 
synaptosomal fraction (top and middle panel respectively). β-Actin was used as a loading 











4.5 In silico analysis of DAT proteome:  
 
Studies suggest that genes encoding interacting proteins have similar mechanisms 
of transcriptional regulation (Ge et al., 2003). WebQTL (Chesler et al., 2004; Chesler et 
al., 2003; Wang et al., 2003) databases were used to answer two questions: 1) Does the 
expression of 21 DAT-associated proteins (listed in Table 2 excluding actin, including 
DAT and α-synuclein) co-vary? Co-variation would imply a common pattern of gene 
expression, which would in turn, suggest a functional interaction of these proteins. 2) Do 
transcript abundance values of these proteins correlate with phenotypes functionally 
related to the dopamine transporter? To investigate the first question we carried out 
principal component analysis (PCA). PCA is a dimensionality reduction procedure often 
used for searching common pattern among investigated variables (Landgrebe et al., 
2002). PCA is based on a correlation matrix of variables of interest. Thus, it reduces the 
dimensionality of the data matrix while capturing the underlying variation and 
relationships among the variables. Principal component 1 (PC1) is a new PCA variable 
that accounts for the largest proportion of data variance. The proportion of variance 
explained by PC1 generally reflects how well variables correlate with each other. 
Principal component 1 (PC1) of the set of 21 DAT proteome genes accounted for about 
34% of data variation (Figure 11). By comparison, the mean value of PC1 of 100 
different sets of 21 randomly selected genes from the forebrain expression dataset (total 
of 12,422 expression traits) was 24% + 4% (SD). Thus DAT proteome PC1 deviates 
more than 2.5 SD from the estimated population mean, indicating a non-random 
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intercorrelation pattern among the 21 DAT proteome genes. PCA of 21 DAT proteome 
genes also distinguished a group of 9 genes. These genes had high loading scores (a 
measure of the contribution of the variables to the principal component) for PC1 and 
clustered in a 2-dimensional (PC1 vs PC2) space (encircled in black, Figure 11). Most 
correlations among members of this subset were highly significant (data not shown). 
 The second question of functional relevance was addressed by calculating genetic 
correlations between expression values of 21 DAT proteome genes and 7 phenotypes 
listed in BXD Published Phenotypes database (www.webqtl.org). The 7 phenotypes are 
listed in Table 3, supplementary information. These phenotypes could be classified as 
functionally related to DAT and were chosen as representatives from a number of related 
traits from the same studies. Both genetic transcript and phenotype data including record 
numbers for phenotypes and Affymetrix probeset ID numbers for the 21 genes are listed 
in (Table 3). Two of the phenotypes studied were DAT density in male Nucleus 
Accumbens and Caudate Putamen of male mice. Interestingly, the only significant 
correlation between any transcript and DAT density detected was a negative correlation 
between DAT mRNA and DAT density in Caudate Putamen (r=-0.59, p<0.01), 
suggesting a negative feedback regulation of DAT abundance. In addition, mRNA levels 
of Rasgrf2, Brca2, Pard3 and Ap1b1 were also correlated with some cocaine-induced 






Figure 11: Results of in silico analysis using WebQTL database. A) Results of PCA on 
the 21 DAT-related genes are plotted on a 2-dimensional diagram, with PC1 and PC2 
loadings for each gene being shown. 9 genes with similar loading patterns are encircled 
in black. Bcan-Brevican, Kcnb1-KV2.1, Aco2-Similar to mitochondrial aconitase, Dnm-
Dynamin, Kif3b-Kinesin related protein Kif3b, Cspg3-Neurocan, Tuba6-Tubulin, Snca-
α-Synuclein, Rasgrf2-Ras GRF2, Cftr-Cystic fibrosis transmembrane conductance 
regulator, Aldo1-Fructose bis phosphate Aldolase, Syn1-Synapsin1, Rgnef-Rho GEF, 
Kcnd3-Kv4.3M, Pclo-Piccolo, Ap1b1-Adaptor protein 1 beta, Synj2-Synaptojanin2, 







Table 3: Genes and phenotypes extracted from the WebQTL project and used for PCA 
 
and/or correlational analysis. See Methods for details 
 
Gene/Phenotype description Phenotype/ ID # in WebQTL
Gene Symbol
Dopamine transporter expression in Nucleus Accumbens - males DAT_NA 10591541-25-BXD
Dopamine transporter Caudate Putamen - males DAT_CP 10591541-28-BXD
Cocaine stereotypy - number of movements 45 mg/kg cocaine ip (Difference from saline) - males S_45 10591541-65-BXD
Cocaine Open Field Activity - total distance 45 mg/kg cocaine  (Difference from saline) - males O_45 10591541-68-BXD
Locomotor activity post cocaine (32 mg/kg) [activity counts/hr] L_32 7932176-01-BXD
Sensitization of locomotor response to cocaine (32 mg/kg) [% initial response] SE_32 7932176-02-BXD
Stereotypical behavior frequency post daily cocaine injection (32 mg/kg), day 8 S_32 7932176-03-BXD
Potassium channel, delayed rectifier, subtype 1, gene 1 Kcnb1 101308_at
RAS protein-specific guanine nucleotide-releasing factor 2 Rasgrf2 102572_at
Breast cancer 2 Brca2 102911_at
Dynamin Dnm 103031_g_at
Aldolase 3, fructose-bisphosphatase Aldo1 160546_at
Par-3 (partitioning defective 3) homolog (C. elegans) Pard3 160607_at
Kinesin family member 3b Kif3b 161003_at
Brevican Bcan 92700_at
Rho-guanine nucleotide exchange factor Rgnef 92710_at
Synuclein, alpha Snca 93273_at
Synapsin 1 Syn1 93730_at
Cystic fibrosis transmembrane conductance regulator Cftr 94757_at
Adaptor-related protein complex AP-1, beta 1 subunit (beta-prime adaptin) Ap1b1 95704_at
Aconitase 2, mitochondrial Aco2 96870_at
Piccolo (presynaptic cytomatrix protein) Pclo 97753_at
Solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 Slc6a3 97787_at
Synaptojanin 2 Synj2 97962_at
Tubulin, alpha 2 Tuba6 98759_f_at
Chondroitin sulfate proteoglycan 3 Cspg3 98799_g_at
Potassium voltage gated channel, Shal-related family, member 3 Kcnd3 99371_at











Table 4: Data from the WebQTL project. Pearson’s correlation coefficients among the 28 variables of interest. 
Phenotypes/Gene symbols are shown in the left column (See Table 2 for variable details). Shown in bold are the correlations 
between DAT-related phenotypes and DAT-related transcripts. 
 
DAT_NA DAT_CP S_45 O_45 L_32 SE_32 S_32 Kcnb1 Rasgrf2 Brca2 Dnm Aldo1Pard3 Kif3b Bcan Rgnef Snca Syn1 Cftr Ap1b1 Aco2 Pclo Slc6a3 Synj2 Tuba6 Cspg3 Kcnd3
DAT_CP 0.47
S_45 0.27 0.27
O_45 0.23 0.14 0.52
L_32 -0.15 -0.30 0.24 -0.10
SE_32 -0.19 -0.29 0.01 0.11 -0.67
S_32 0.14 -0.06 0.04 -0.03 0.49 -0.77
Kcnb1 0.27 0.44 0.14 -0.11 0.15 -0.42 0.20
Rasgrf2 0.13 -0.08 0.06 -0.18 0.43 -0.64 0.34 0.49
Brca2 0.02 -0.21 -0.32 -0.40 -0.44 0.57 -0.52 -0.12 0.15
Dnm -0.02 -0.01 -0.15 0.03 0.20 -0.23 0.04 -0.20 0.05 -0.33
Aldo1 -0.18 -0.06 -0.33 -0.07 -0.05 -0.14 0.00 -0.19 0.00 -0.20 0.86
Pard3 0.18 -0.10 0.22 0.51 -0.06 0.45 -0.14 -0.32 -0.52 -0.12 -0.11 -0.26
Kif3b 0.23 0.35 0.05 -0.12 -0.10 -0.26 0.09 0.58 0.28 0.08 -0.38 -0.27 -0.41
Bcan -0.32 0.10 0.07 0.30 0.20 -0.48 0.20 0.14 0.18 -0.35 0.63 0.47 -0.18 0.00
Rgnef 0.10 0.32 0.09 0.17 -0.34 0.10 0.12 0.26 -0.07 0.05 -0.63 -0.61 0.24 0.51 -0.17
Snca 0.38 0.09 -0.02 -0.12 -0.11 0.39 -0.11 -0.03 -0.01 0.40 -0.49 -0.53 0.18 -0.08 -0.58 0.31
Syn1 -0.14 0.25 0.14 0.08 -0.25 0.24 0.10 -0.13 -0.12 -0.27 0.18 0.30 0.08 -0.23 -0.05 -0.05 -0.04
Cftr 0.32 -0.05 -0.13 0.17 -0.02 0.11 -0.13 -0.14 0.07 -0.09 0.62 0.53 0.06 -0.26 0.18 -0.35 0.18 0.12
Ap1b1 -0.06 -0.07 -0.08 0.07 0.25 -0.57 0.26 0.14 0.18 -0.52 0.73 0.72 -0.37 0.03 0.70 -0.50 -0.79 0.03 0.29
Aco2 -0.09 -0.17 -0.16 0.06 0.16 -0.18 0.01 -0.28 0.10 -0.27 0.96 0.88 -0.18 -0.35 0.59 -0.67 -0.49 0.18 0.66 0.74
Pclo 0.35 0.01 -0.23 -0.11 -0.08 0.27 -0.08 0.05 0.05 0.39 -0.52 -0.43 0.23 0.00 -0.70 0.29 0.72 -0.19 0.09 -0.64 -0.49
Slc6a3 -0.41 -0.59 -0.05 -0.05 0.49 -0.46 0.26 0.13 0.37 -0.15 0.12 0.08 -0.42 0.08 0.26 -0.33 -0.30 -0.23 -0.12 0.39 0.20 -0.26
Synj2 0.12 0.06 0.19 0.17 0.04 -0.10 0.12 -0.10 0.06 -0.21 -0.13 -0.36 0.13 -0.13 -0.04 0.25 0.37 -0.04 0.12 -0.24 -0.15 0.08 -0.15
Tuba6 -0.04 -0.18 -0.29 -0.10 0.20 -0.12 -0.05 -0.32 0.10 -0.18 0.86 0.81 -0.18 -0.41 0.30 -0.74 -0.28 0.18 0.66 0.58 0.87 -0.25 0.19 -0.22
Cspg3 0.08 0.13 0.14 -0.27 -0.12 0.13 -0.27 0.10 0.31 0.33 -0.20 -0.21 -0.38 0.44 -0.12 0.27 -0.06 -0.22 -0.31 -0.16 -0.17 -0.02 0.10 -0.13 -0.23
Kcnd3 -0.09 -0.07 -0.17 -0.38 0.32 -0.10 0.00 -0.10 -0.10 -0.21 0.65 0.53 -0.25 -0.14 0.29 -0.63 -0.15 0.08 0.47 0.46 0.63 -0.37 0.16 -0.17 0.67 -0.25







regulating transporter function. For example, the function of the GABA and SERT are 
2A respectively, two proteins that have 
plex with the transporters (Bauman et al., 2000; Deken et al., 
plex with and regulate 
ne transporter function are lacking, and our work is the first to use an interaction 
e.  
oaches are widely used to elucidate 
el et al., 2002; Ho et al., 2002; Husi et al., 2000). In 
inus of DAT to isolate 
ing the presence 
-synuclein in the DAT complex (Lee et al., 2001). Our approach identified 20 
ng proteins, ion channels and metabolic 
e of the proteins that are found to be 
plexes. 
 a band of approximately 70-80 kDa. Synapsin 1b belongs to a 
ily of phosphoproteins that are involved in regulating neurotransmitter release 
eviously that syntaxin 1A, a protein also 
There is growing evidence that protein-protein interactions play a vital role in 
regulated by syntaxin and protein phosphatase 
been shown to exist in a com
2000). However, global studies of proteins that exist in a com
monoami
proteomics based approach to elucidate a transporter proteom
Antibody and affinity purification based appr
protein-protein interactions (Becam
this study we used an antibody directed towards the N-term
proteins associated with DAT. This approach was validated by confirm
of α
candidate proteins which were involved in various cellular functions including cell 
surface trafficking, cell adhesion, scaffoldi
enzymes. It is, of course, possible that som
associated with DAT are artifactual interactions caused by detergent-based extraction 
used to isolate these protein com
Two proteins, DAT and synapsin 1b, were identified as high probability hits with 
peptides derived from
fam
(Greengard et al., 1993). It has been shown pr
 
involved in regulating neurotransmitter release, interacts directly with the GABA 
transpo
ed 













rter and regulates its function (Deken et al., 2000) providing an elegant 
mechanism to couple neurotransmitter release to reuptake. Thus, it is tempting to 
speculate that synapsin Ib plays a similar role in coupling transmitter release to DAT 
function. Synapsin also interacts with actin (which is a component of the DAT complex) 
and it is possible that interaction of DAT with synapsin 1b could be indirectly mediat
through actin. 
Four peptides corresponding to Kv2.1 alpha subunit, a po
d by mass spectrometry in the DAT complex. Kv2.1 alpha subunit is widely 
expressed in the brain and its expression is restricted to the soma and proximal dendrites
in cortical and hippocampal neurons (Murakoshi and Trimmer, 1999). There is also
evidence for expression of Kv2.1 in axons and neuronal terminals in rat cerebellar baske
cells (Tan and Llano, 1999), but the subcellular localization of Kv2.1 in the striatum
not been examined. Our study suggests that Kv2.1 is localized to striatal synaptosom
and is enriched in the synaptosomal fraction. This implies a common subcellular 
localization for DAT and Kv2.1 in the striatum, although this needs to be confirm
immunohistochemical studies. In globus pallidus (GP) neurons, the ratio of Kv2.1 to 
Kv3.1/3.2 channels determines the discha
 alteration in the expression levels of these channel types could lead to burst-firing 
observed in GP neurons after treatments or due to diseases that reduce dopamine leve
(Baranauskas et al., 1999). Recent studies suggest that DAT-associated currents can
modulate neuronal excitability (Ingram et al., 2002) and association of DAT with Kv2.1
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could provide a novel mechanism by which DAT could control neuronal excitabili
modulate neurotransmitter release. Although, functional association of neurotra
receptors with ion channels has been established (Law et al., 2000), this is the first
of association between a neurotransmitter transporter and an ion channel.  
We also identified dynamin I, a protein involved in synaptic vesicle recycling. 













ent process (Zahniser and Doolen, 2001). Hence, the association of dynamin I 
with DAT could also have a functional role in regulating DAT trafficking in vivo. 
Brca2 was detected as a medium probability hit in our screen for DAT interacting 
proteins. Brca2 is a nuclear protein involved in the maintenance of chromosome struc
and mutations in the gene encoding Brca2 render susceptibility to breast and ovarian 
cancers (Venkitaraman, 2002), but our results point to an additional role for this protein 
in brain, perhaps by regulating DAT function. We were unable to detect Brca2 in the 
synaptosomal fraction. A number of factors may account for this finding. Due to i
size (~400 kDa), the Western transfer conditions may need to be altered substantial for 
Brca2 to be detected. Interaction between DAT and large proteins such as Brca2 may 
be stable in this preparation. It is also possible that DAT/Brca2 interactions may be 
localized to neuronal compartments that are absent in synaptosomal preparations.  
Neurocan was detected as a high probability hit in the DAT complex. Neurocan i
a chondroitin sulphate proteolycan whose expression is developmentally regulated. In
adults, neurocan is proteolytically cleaved to a 130 kDa core protein with an average 
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molecular mass of ~200 kDa (Rauch et al., 2001). Neurocan is an extracellular matrix 
associated protein that is a ligand for tenascin-R and NCAM (Dityatev and Schachner, 
2003). Neurocan has been implicated in the organization of striatal compartments in vivo 
(Charvet et al., 1998).  
The cytoskeletal proteins, actin and tubulin were detected as high probability hi
in our analysis. We also detected kinesin related protein 3b (KIF3b), a motor protein 
involved in vesicular transport and highly enriched in the brain (Yamazaki et al., 1995).
KIF3b is part of the kinesin II complex, which plays an important role in insulin-
stimulated glucose transporter 4 (GLUT4) trafficking (Imamura et al., 2003). Henc
ts 
 







e that KIF3b is involved in the transport of vesicles containing DAT to the cell 
surface. The metabolic enzymes, aldolase, triose phosphate isomerase and similar to 
mitochondrial aconitase were also immunoprecipitated with the DAT complex. These
enzymes are highly expressed in the brain and there is evidence that these metabolic 
enzymes interact with tubulin (Walsh et al., 1989). It is possible that these proteins ex
in a complex with DAT via their interactions with tubulin. 
The scaffolding proteins PAR-3 and aczonin were detected in our analysis. 
Scaffolding proteins are important because of their ability to nucleate multiprotein 
complexes. Aczonin is a presynaptic cytomatrix protein that is involved in synapse 
assembly. Aczonin possesses numerous protein interaction motifs including a C-ter
main and is thought to play a role in localizing exo and endocytic machinery 
(Garner et al., 2000).  PAR-3 is an 180kDa adaptor protein containing 3 PDZ domains.
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is highly expressed in the embryonic and adult striatum and known to play a role in the
development of neuronal polarity (Lin et al., 2000). 
The C-terminal tail of DAT has been shown to interact with PICK-1 (via its PDZ 
domain), α-synuclein, a
 





D-95 and NMDA receptor 
proteom
g on 
out using yeast and C.elegans proteome and transcriptome data suggest that genes 
tern Blotting neither PICK-1 nor Hic 5 were detected. A possible reason for this 
could be the co-migration of PICK1 and Hic5 with the IgG heavy chain.  It is also 
possible that PICK1 and Hic 5 do not associate with DAT under the conditions used for 
isolating the DAT complex in this study. 
We also compared the components of the DAT proteome with the recently 
published PSD-95 (Peng et al., 2004) and the NMDA receptor proteome (Husi et al., 
2000). Of the 347 proteins identified as components of the PSD-95 proteome, there ar
only 8 proteins that are also detected in the DAT proteome. There are only 3 proteins th
overlap between the DAT and the NMDA receptor proteome. This further illustrates t
members of the DAT proteome are discrete and do not show significant overlaps with 
that of two other widely receptor protein complexes, the PS
es. 
The relationships between mRNA and protein levels are complex. Dependin
the specific gene class, genetic system and treatment conditions the mRNA-protein 
correlations can range from 0 to 0.9 (Greenbaum et al., 2003). Interestingly, several 
studies suggest a robust correlation between gene expression profiles and protein 
interaction datasets (see (Ge et al., 2003)for review). For example, some studies carried 
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encoding interacting proteins more likely belong to common gene expression clusters (G
et al., 2003). Hence it can be hypothesized that the ge
e 





vestigation using these databases provided 
evidenc ns 
 




ssociated genes are part of a common transcriptome cluster. To test this hypothesis
we used the WebQTL Project (web-based databases) that has been recently introduced to
scientific community and proved to be a powerful tool for hypothesis driven 
investigations (Chesler et al., 2004; Chesler et al., 2003; Wang et al., 2003). Specif
the WebQTL databases are useful for studies of regulation of gene expression and geneti
mechanisms of complex traits. In silico in
e for potential functional relationships among the 21 DAT-associated protei
detected by mass-spectrometry in the present study. PCA suggested a co-regulation of
expression of these genes, while correlational analysis of gene expression and DAT-
related phenotypes suggested involvement of several genes in DAT function. However, 
these in silico analyses do not substitute for a formal validation of the results. There are 
several limitations of the WebQTL data sets. For example, the brain region used for 
mRNA extraction in the WebQTL project was much larger than the one used in the 
present stud
 global pattern that could not be specific for striatum of DBA mice. Another 
limitation concerns the relationships between gene expression and behavior. A 
correlation between mRNA abundance and behavior only suggests but does not indic
mechanistic involvement of this transcript in the behavior of interest because of 




to be an important hypothesis-generating tool that assisted greatly in potential target lists 
for future investigation.  
Studies indicate that DAT function is sensitive to modulation by ethanol (Maiya 
et al., 2002; Mayfield et al., 2001). Hence we examined if any of the DAT-associated 
proteins map to QTL’s for alcohol-related behaviors. Kv2.1 and Kif3b also m
for alcohol-induced loss of righting reflex (Markel et al., 1997). Dynamin I maps to a 
QTL for alcohol preference drinking (Melo et al., 1996). 
In summary, the mass spectrometric approach identified a network of function
diverse proteins that exist in a complex with DAT and may play a role in regulating DA
activity. Our work suggests that combining proteomics approaches with emerging 
genomic and genetic databases can facilitate such studies. Future studies will investig
the functional consequences of these interactions and examine how this network is 
















 Chapter 5 
 
 






The goal of specific aim 2 was to examine ethanol effects on cell surface 
trafficking of DAT. GFP-tagged wild type and G130T DAT were generated and 
transfected into mammalian cell lines to visualize ethanol-mediated trafficking events. 
Ethanol induced changes in DAT function and localization were monitored by [3H]DA 
uptake experiments as well as by monitoring changes in localization of GFP-tagged 
transporters in real time. Characterizing ethanol effects on DAT function in a mammalian 
cell line will also enable us to address part of Aim 3, which is to identify proteins that 
associate differentially with wildtype and G130T DAT. The results from these 
experiments will be summarized in this chapter. 
 
5.2 Effects of Ethanol on Madin Darby Canine Kidney (MDCK) Cells Stably 
Expressing DAT. 
MDCK cells stably expressing the human DAT were obtained from Dr. Susan 
Amara’s laboratory (Vollum Institute, Oregon). The cells were grown to 60-80% 
confluence. These cells were exposed to ethanol (100 mM) for 1 hour in KRH buffer 
                                                 
∗ Experiments showing ethanol modulation of GFP-DAT function in midbrain slices were 
perform d by Angela Ozburna.  David Galindo performed the experiments showing 
ethanol modulation of DAT function in NG108 cells. All other experiments were 






(Methods) at room temperature. DAT function was assayed by exposing these cells to 
[3H]DA for 10 minutes in the presence of ethanol. Ethanol potentiated DAT function by 
0% (Figure 12). These results indicate that ethanol potentiation of DAT function is not 



























































Figure 12: Effect of ethanol on MDCK cells stably expressing GFP-tagged DAT.  
DCK cells stably expressing GFP-labeled DAT were exposed to 100 mM ethanol for 1 
hour and [3H]DA uptake was measured. Ethanol enhanced [3H]DA uptake by 80% in 















5.3 Effect of ethanol on SH-SY5Y cells stably expressing the human DAT 
 
Recent site directed mutagenesis experiments in the Xenopus oocyte expression 
system suggest that discrete amino acids in the first intracellular loop are important for 
ethanol modulation of DAT function (Maiya 2002). In addition, proteomics data suggests 
that DAT belongs to a complex of interacting proteins. These proteins may play a role in 
regulating cell surface trafficking of DAT. Identification proteins associated with 
wildtype and ethanol insensitive mutant transporters will provide valuable insight into 
ethanol induced alterations in DAT function. An interaction-proteomics based approach, 
using antibodies directed to wildtype and G130T DAT could be used to identify 
differences in the proteins that associate with these transporters. Thus ethanol’s effects on 
ce DAT regulation in these cells might 
closely mimic that in midbrain DA neurons (Jiang et al., 2004; Shamoto-Nagai et al., 
2004). Human neuroblastoma cells were used because they are more amenable to 
proteomics-based approaches (because of a fully sequenced genome). Since stable cell 
lines have the advantage of expressing consistent levels of protein over time, SH-SY5Y 
cells stably expressing GFP-tagged wildtype and G130T DAT were generated. 
SH-SY5Y cells stably expressing DAT were generated as described (Methods). 
Seven clones were isolated and screened for DAT expression and four stably expressing 
DAT clones were selected based on the level of expression of DAT.  The clones selected 
could be classified as high, medium, and low expressors (based on their [3H]DA uptake 
DAT function in human neuroblastoma SH-SY5Y cells were investigated. SH-SY5Y 
cells resemble dopaminergic neurons and hen
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characterestics). The ability of ethanol to alter DAT function in these clones was tested 





ere then exposed to [3H]DA in the presence of ethanol for 10 minutes and the 
amount of radioactivity taken up was measured by liquid scintillation spectroscopy. The
clones were all insensitive to ethanol. One of the clones (clone# 13) displayed a trend 
towards potentiation (25%) but this was not statistically significant (Figure 13). It is 
possible that longer exposure times to ethanol and/or incubation at 370C are requir



























Figure 13: Ethanol effects on SH-SY5Yclones stably expressing GFP-DAT. 
Four clones stably expressing GFP-DAT were exposed to ethanol for 1 hour and [3H]DA 
uptake values were measured. Values are expressed as % of control with the control set to 
100%. Clone 13 shows slight potentiation (25%) in DAT function upon ethanol exposure 
ut this was not statistically significant. Mean values +b  SEM are shown. N=7 for clone 13 











5.4 Generation of sindbis viral particles encoding GFP-tagged DAT 
 
Protein trafficking regulates the function of a number of synaptic proteins 
(Buckley et al., 2000). Numerous studies suggest that the function of neurotransmitter 
transporters at the cell membrane is also regulated by trafficking events (Zahniser and 
Doolen, 2001). This mode of regulation plays a vital role in controlling the dynamics of 
neurotransmission. The aim of the experiments discussed in this section was to examine 
in real time the trafficking of DAT as a mechanism underlying the synaptic 
neuroadaptation to ethanol. The experimental design involved observation of GFP-DAT 
trafficking in primary cultures from mouse mesolimbic neurons using confocal and real 
time two-photon fluorescence imaging.  
 mesolimbic 
indbis virus is a plus strand RNA virus belonging to the Alphavirus genus of the 
ogaviridae family. The sindbis virus has been shown to preferentially infect neuronal 
ells. The sindbis viral gene delivery system has several advantages as compared to other 
iral vectors. They have a higher efficiency and specificity of infection of neuronal cells 
nd also demonstrate a rapid onset of gene expression (Ehrengruber, 2002). 
BHK cells were electroporated with mRNA encoding GFP-tagged DAT as 
escribed (Methods). Fluorescence was monitored 12-24 hours post transfection. 70% of 
e cells were transfected with GFP-tagged DAT (Figure 14A). To determine the 
To study trafficking events that regulate transporter function in mouse
neurons, sindbis virus-mediated gene delivery system was generated and used to infect 










functionality of the GFP-tagged DAT, [3H]DA uptake experiments were carried out 24 
ours post transfection. Significantly higher [3H]DA uptake was observed in cells 












































































Figure 14: Expression of functional GFP-tagged transporters in BHK cells. A) BHK cells 
were electroporated with RNA encoding EGFP-DAT and helper virus RNA. Cells were 
imaged 12-24 hours post transfection. Greater than 70% of the cells expressed GFP-DAT. 
B) Virions were harvested and used to infect a fresh monolayer of BHK cells and 
[3H]DA uptake was measured as described. Specific [3H]DA uptake was measured in 











The viral particles generated were also tested for their ability to infect neuronal 
cells in culture. Cortical neurons were cultured and infected with GFP-tagged viral 
particles as described. The neurons were imaged 24 hours post-infection. The neurons 
were uniformly labeled with GFP-tagged transporters. Fluorescence could be visualized 
in dendrites as well as in the terminals (data not shown). The sindbis viral particles 
expressing GFP-tagged DAT were successfully used to infect cultured cortical neurons. 
Next, the viral particles were used to infect intact neurons in slices. Explants were 
generated from VTA and infected with sindbis viral particles as described (Methods). 
The explants were visualized using a 2-photon microscope 24 hours post-infection 
(Figure 15). GFP-labeling could be observed in both the explants in the cell body and 
rminal regions. Hence, the sindbis viral particles generated could be used to infect a 










Figure 15: Expression of GFP-DAT in mesolimbic slice explants. Mesolimbic explants 
ere prepared and infected with recombinant sindbis virus particles as described. The 
ices were imaged 24 hours post-injection using a two-photon microscope. Z-scans of 
fected neurons in mesolimbic slice explants are depicted. In both types of explants 














5.4.1 Effects of ethanol on GFP-DAT expressed in mouse midbrain DA neurons 
 
Primary cultures of midbrain neurons were prepared and plated to a density of 
100,000 cells/ml on glass coverslips in 24-well culture dishes (methods). Cultures were 
maintained for 1 week before infection with recombinant sindbis viral particles encoding 
GFP-DAT. Purified virus was added directly to the media 24 hours prior to ethanol 
treatment. Under these conditions approximately 80% of the neuronal population 
expressed the fusion protein. Simultaneous z-section scanning for GFP fluorescence was 
performed in the absence and presence of ethanol (100 mM). The media was replaced 
with artificial cerebrospinal fluid (aCSF) and control images were taken after 120 and 
150 minutes of equilibration. The cells were then exposed to ethanol (100 mM) and 
imaged after 10 and 30-minute exposure. Each cell served as its own control. Computer 
generated control and experimental images of two representative neurons were compared 
l 
ion of time. 
hese changes are represented by the graded color changes indicated by the arrows. A 
hange in the distribution of fluorescence intensity could be observed around the cell 
ody and dendrites of both cells (top and bottom panel) after 10-minute ethanol exposure. 
he z-series of each image has been arithmetically compressed so that composite 
luorescence can be visualized in a single plane. Thus, 10-15 images contribute to the 
pparent heavy fluorescence observed.  
to determine GFP-DAT redistribution (Figure 16). Fluorescence was observed in the cel
body, axons, and in distal dendrites of infected neurons. The image series B-D (top and 
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Figure 16: Effects of ethanol on GFP-DAT expressed in midbrain DA neurons. 
DAT. Simultaneous z-section scanning for GFP fluorescence were performed in the 
150 min after equilibration with aCSF. Cells were then exposed to ethanol (100 mM) and 
 
patterns of GFP-DAT distribution. Raw and pseudocolored z-scans of two infected 
 














Midbrain neurons were cultured and infected with Sindbis viral particles encoding GFP-
absence (control) and presence of ethanol (100 mM). Control images were taken 120 and 
imaged after 10 and 30 min exposure. Metamorph analysis package was used to compare
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Ethanol’s effects on DAT function in mammalian cells expressing DAT were 
examined. Results obtained from MDCK cells stably expressing DAT and HeLa cells 
transiently expressing DAT show that ethanol potentiates DAT function in mammalian 
cells (by 80% and 30% respectively). These results suggest that ethanol’s effects on DAT 
restrict xpression sy ere ethan  
an approximately 30% enhancement in DAT function. It is still unclear whether the 
mechanism by which ethanol potentiates DAT function in MDCK cells is similar to that 
in Xenopus oocytes. Attempts to monitor changes in the cell surface distribution of DAT 
 confocal microscopy in MDCK cells have been inconclusive. Cell surface 
biotinylation techniques may be needed to observe the subtle changes in transporter 
ed in neuroblastoma cell lines that are derived from neurons. 
Ethanol’s effects on DAT function in SH-SY5Y cells stably expressing DAT 
ere examined. SH-SY5Y cells are neuroblastoma cells and resemble DA neurons in 
ulture. Four clonal SH-SY5Y cell lines with different expression levels (classified as 
edium, high and low) of DAT were chosen for ethanol studies. Ethanol had no effect on 
AT function in the four clones tested. Clone # 13 showed a trend towards potentiation 
(25%) but this was not significantly different from the control. Numerous reasons could 
ed to the Xenopusfunction is not  oocyte e stem, wh ol caused
by
density caused by ethanol exposure. It is also possible that the mechanism of ethanol 
action in MDCK cells might differ from that in oocytes and occur through a trafficking 
independent mechanism.  The regulation of DAT in MDCK cells, which are epithelial in 








account for the observed discrepancy in ethanol effects between MDCK cells and SH-
Y5Y cells. It is possible that longer ethanol exposure times are required to potentiate 
DAT function in SH-SY5Y cells. It is also possible that the temperature of incubation 
with ethanol plays a crucial role in ethanol potentiation of DAT function. Preliminary 
results using SK-N-SH and NG108 cells transiently transfected with DAT suggest that 2-
hour exposure to ethanol at 370C causes robust potentiation of DAT function (Mayfield 
and Galindo, personal communication). It is possible that a similar paradigm of ethanol 
exposure is necessary to potentiate DAT function in the SH-SY5Y cells stably expressing 
DAT and experiments are currently underway to standardize these conditions. 
To study changes in DAT trafficking in cultured neurons and neuronal explants, a 
sindbis viral construct expressing GFP-tagged DAT was generated. The viral particles 
generated were used to successfully infect neurons in culture as well as VTA explants. 
These viral particles were also used to deliver GFP-tagged DAT into the VTA of mice. 
Midbrain DA neurons were infected with sindbis viral particles encoding GFP-DAT and 
imaged in the presence and absence of ethanol (100 mM) in real time. Preliminary 
analysis of fluorescence distribution patterns in the presence and absence of ethanol 
suggest that even a 10-minute exposure to ethanol can cause changes in pattern of 
distribution and intensity of fluorescence in these neurons. These changes need to be 
quantitated to evaluate if they are significantly different from the control images. 
The results outlined above validate the approach of using viral delivery systems to 
monitor GFP-DAT trafficking in a variety of neuronal preparations. Currently studies are 




exposure. Cell surface biotinylation experiments could also aid in dissecting the 
mechanism by which ethanol alters cell surface trafficking in these cells. Techniques 
developed for viral mediated gene delivery and confocal imaging through the course of































 projecting on to the striatum and NAc area respectively. This circuitry has 
been widely implicated in mediating the rewarding and reinforcing effects of various 
drugs of abuse (Wise, 2002). DAT is an important member of this pathway and controls 
the spatio-temporal dynamics of DA neurotransmission by mediating reuptake of DA into 
the presynaptic neuron. DAT is also the site of action of various psychostimulants like 
cocaine and amphetamine. These drugs function by inhibiting DA uptake by DAT and 
the resulting increases in extracellular DA are thought to mediate in part the rewarding 
and reinforcing effects of these drugs of abuse (Gainetdinov et al., 2002). 




ffects of ethanol, unlike most drugs of abuse involve multiple neurotransmitter 
and receptor systems in multiple brain regions (Harris, 1999). The effects of ethanol on 
various properties of midbrain DA neurons have been examined and the results are 
controversial. Ethanol has been shown to enhance the firing rates of VTA DA neurons 
nd cause increases in extracellular DA concentrations in the NAc (Di Chiara and 
perato, 1988). Ethanol has also been shown to enhance DA release in the NAc of rats 







VTA or NAc has been shown to reduce forcement (Weiss and Porrino, 2002). 
These and other studies support a role for DA in the reinforcing actions of ethanol. 






 suggests that 
ethanol decreases extracellular DA in the striatum and this effect occurs through 
1). This effect is 






ement is independent of DA systems (Ikemoto et al., 1997). 
Evidence for ethanol’s effects on DAT function in vivo have been controversial. 
Numerous studies have examined the effects of ethanol on dialysate DA concentration
the brain. One study examining ethanol’s effects on DA clearance in the striatum in rats 
suggest that local exposure to ethanol enhances DA clearance (Wang et al., 1997). 
Chronoamperometric studies on DA clearance in the dorsal striatum of rats injected wit
ethanol also suggest that DAT function is upregulated (Sabeti et al., 2003). These studie
are consistent with our findings in Xenopus oocytes and MDCK cells that acute exposur
to ethanol can enhance DAT function. However, a recent voltametry study
decreased release and not increased reuptake (Budygin et al., 200
h
ating decreased DA levels in the striatum. Numerous microdialysis studies also 
suggest that ethanol enhances synaptic DA concentrations presumably by a mechanism 
involving enhanced release of DA (Yim and Gonzales, 2000). These results appear t
conflict with our findings suggesting that ethanol enhances DA uptake by DAT. 
However, these results were obtained using microdialysis techniques, which do not
directly measure DA uptake. One study (Yim and Gonzales, 2000) has simultaneously 
quantitated dialysate DA levels and extracellular ethanol concentrations. The results fro
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this suggest indicate that dialysate DA levels return to baseline even when ethanol levels 
continue to remain high. This temporal mismatch between dialysate DA and ethanol
levels could result from ethanol enhancement of DAT function (Mayfield et al., 200












ism that occurs to counter-balance the increase in extracellular DA concentration
mediated by ethanol. This mechanism could contribute to acute functional tolerance that 
is observed for DA-mediated responses (Holman and Snape, 1985; Mullin and Ferko, 
1983). It is also possible that enhanced DAT function could contribute to the decrea
mesolimbic dopaminergic activity (Shen and Chiodo, 1993) and decrease in extracellular 
DA concentrations (Diana et al., 1993) observed during ethanol withdrawal. Hence, 
changes in DAT density may also contribute to ethanol withdrawal symptoms and may 
motivate ethanol seeking in dependent individuals. 
Relatively few studies have focused on the role of presynaptic neurotransm
transporters in ethanol-induced neuroadaptation. The significance of this work was
elucidation of a novel mechanism by which ethanol could inactivate the dopaminergic 
pathways. In addition, effects of ethanol on protein interactions and trafficking defined b
these studies could also apply to additional receptor systems. The use of gene delivery 
and proteomics techniques is very limited in alcohol research and this work provides 
applications of these techniques to this field. This is also the first study to carry o
comprehensive analysis of the DAT proteome. Defining this important complex will
us valuable insight into the signal transduction pathways that regulate the function of 
DAT and other neurotransmitter transporters. 
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6.2 Ethanol’ s effects on DAT expressed in Xenopus oocytes 
 
Ethanol enhances [3H] and cold DA uptake by DAT in Xenopus oocytes 
express of 
 





cid residues to the corresponding residue 
ing DAT. This enhancement was accompanied by an increase in the number 
cell surface transporters. Treatment of oocytes with cycloheximide, a protein synthesis 
inhibitor did not alter ethanol-induced enhancement of [3H]DA uptake suggesting that 
enhancement of DA uptake by ethanol is not protein synthesis  dependent (Mayfield et
al., 2001). Ethanol has been shown to alter trafficking of neuronal proteins; for example, 
ethanol exposure causes translocation of the catalytic subunit of PKA (subunit C alpha) 
from the golgi to the nucleus (Dohrman et al., 1996). Ethanol exposure also induces 
trafficking of receptor for activated C kinase 1(RACK1) from the cytoplasm to the 
nucleus (Ron et al., 2000). The data discussed above
nction in a similar manner by altering DAT trafficking. 
Experiments also suggest that ethanol has contrasting effects on DAT and NET 
function. Studies on human DAT and NET function expressed in HeLa cells as well as 
vivo electrochemistry studies suggest that ethanol enhances DAT function but inhibits 
NET function. Ethanol sensitivity of chimeras generated between DAT and NET were 
examined in order to delineate regions on DAT important for ethanol enhancement. 
These chimeras suggest that a region of the transporter spanning regions TMD1-3 was
important for ethanol potentiation. Site directed mutagenesis experiments further 
narrowed this region down to two amino acids G130T and I137 in the first intracellula
loop. Replacement of these individual amino a
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in NET resulted in a mutant transporter that displayed normal DAT function but was 
sensitive to ethanol. Replacement of the first intracellular loop of DAT with that of 
NET re ting the 
uced 




sulted in a mutant transporter that did not traffic to the cell surface, reitera
role of these residues in steady state trafficking of DAT to the cell surface. 
The mechanism by which these residues mediate ethanol potentiation of DAT 
function is not clear. There are no consensus phosphorylation sites for PKC or PKA in 
this region of the transporter. Further, it has been shown that direct phosphorylation of 
the transporter is not required for PKC–mediated regulation of the transporter. These 
results suggest that ethanol-mediated regulation of DAT occurs through a mechanism 
independent of protein kinases and led to the hypothesis that ethanol modulates the 
interaction between DAT and a putative regulatory protein important for ethanol-ind
trafficking of DAT and that this interaction occurs at first intracellular loop. Based on the 
results outlined above, it is possible to outline a model for ethan
n (Figure 1). Ethanol can alter the trafficking of DAT to the cell surface by 
possibly modulating the interaction of DAT with an unknown protein at the first 
intracellular loop. It is still not clear whether ethanol alters DAT function by enhancing
trafficking of DAT to the cell surface or by inhibiting DAT endocytosis. Cell surface 











Figure 17: A schematic illustrating mechanisms of ethanol action on DAT. Ethanol could 
 of 
DAT to the cell surface or by preventing internalization of cell surface DAT. 














6.3 Ethanol effects on DAT function in mammalian cells expressing DAT 
 
Experiments in the Xenopus oocyte expression system suggest that ethanol affects 
DAT function by altering cell surface trafficking of DAT. To visualize such trafficking 
events, GFP-tagged wildtype and G130T DAT transporters were generated and used to 
transfect a variety of mammalian cell lines. 
Ethanol effects were monitored in MDCK cells stably expressing GFP-tagged 
human DAT. Exposure to 100mM ethanol potentiated DAT function in MDCK cells by 
80%. The mechanism by which ethanol potentiated DAT function in these cells is not 
known.  
SH-SY5Y cells stably expressing GFP tagged wildtype and G130T DAT were 
generated. Four different stable cell lines expressing different amounts of wildtype GFP-
DAT were chosen and ethanol effects on DAT function were examined in these cells. 
DAT function was unaffected by ethanol in all four of the cell lines tested. One of the cell 
lines clone # 13 showed a 25% enhancement in DAT function on ethanol exposure. This 
potentiation was not significantly different from that of the control. The ethanol exposure 
ocytes which was 100 mM ethanol for 1 hour at room temperature. It is possible that 
ese conditions need to be altered substantially in order to observe ethanol enhancement 
f DAT function in SH-SY5Y cells. Preliminary observations in NG108 cells, and SK-N-
H cells transiently transfected with GFP-DAT suggest that 2-hour exposure to 100 mM 
thanol at 370C causes robust potentiation (34% and 59% respectively) of DAT function. 








Exposure of SH-SY5Y cells stably expressing DAT to similar conditions may result in 
potentiation of DAT function.  
. The hypothesis to be tested would be that 
change





The enhancement in DAT function reported in this study is modest (30%) and 
dependent on cell types. The best experiment to determine whether DAT plays a role in 
ethanol-induced neuroadaptation would be to manipulate DAT expression levels in vivo 
and monitor changes in ethanol consumption
s in DAT expression levels would alter ethanol consumption. Two groups have 
examined ethanol consumption in recombinant mice lacking DAT and have reached 
opposing conclusions. One study suggests that ethanol consumption is decreased in 
female D
 preference and consumption is enhanced in female DAT knockout animals and
decreased in males (Hall et al., 2003).  The DAT knockout mice also display 
developmental abnormalities and hence may not be well suited for drinking studies. An
alternative to the DAT knockout mice is the DAT knockdown mice where only 10% of 
DAT is expressed compared to wildtype (Zhuang et al., 2001). These hyper-
dopaminergic mice do not display any of the developmental abnormalities observed in 
the DAT knockouts.  
The two strategies discussed above involve reducing cell surface DAT expressi
levels. An attractive approach to monitor consequences of enhanced DAT expression on 
ethanol consumption would be to express DAT in specific brain regions using viral 
expression systems. As a first step towards achieving this goal, a sindbis virus system that
is capable of delivering viral particles encoding GFP-DAT into a variety of neuronal 
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preparations including cultured neuronal cells, slice preparations and in vivo was 
generated. Preliminary results of ethanol exposure in neuronal cells expressing GFP-DAT 
suggest
 
 that a 10-minute exposure to ethanol can induce redistribution and enhance 
fluorescence intensity of GFP-DAT in these cells. These results are however preliminary
and efforts are underway to quantitate these differences and evaluate the functional 
significance of the observed changes.  
 
6.4 The dopamine transporter proteome 
 
Experiments performed in the Xenopus oocyte expression system led us to the 
hypothesis that ethanol modulates the interaction between DAT and a putative regulator
protein important for ethanol-induced trafficking of DAT and that this interac
at the first intracellular loop. However not much is known about proteins that interact 
with and modulate DAT function. So far, yeast two hybrid screens using the C-terminal 
tail of DAT as bait has led to the isolation of three proteins that can directly i
DAT and modulate its function: PICK1, α-synuclein and Hic5. All three of these protei









al signaling is the organization of receptors into multiprotein complexes. Recently, 
the NMDA receptor has been shown to exist as part of a protein complex comprising of 
more than a 75 components (Husi et al., 2000). 5HT2c receptor also exists as part of a
multiprotein complex (Becamel et al., 2002). DAT has numerous consensus sites for 
protein-protein interactions including a C-terminal PDZ domain and leucine repeat mo
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(Torres et al., 2003b). Hence, DAT could also be part of a multiprotein complex. A
interaction proteomics strategy was used to to purify DAT-associated proteins from the 
striatum. An antibody directed towards the N-terminus of DAT was used for this pur
The resulting complex was resolved on a one-dimensional gel. Mass spectrometric 
analysis resulted in the identification of 21 proteins that associate with DAT. These 
proteins could be classified into differe
n 
pose. 
nt functional classes: ion channels, synaptic 
vesicle trafficking proteins, extracellular matrix proteins etc.  
xist in a complex with DAT is schematically 
lustrated in Figure 5. This network was assembled by combining our data with database 
searche r 
aki 
The network of proteins thought to e
il
s. Proteins that are shaded in grey are “missing links”, that is, not detected in ou
screen but have been shown in other studies to interact with proteins that are found in the 
DAT complex in our analysis (Greengard et al., 1993), (Dityatev and Schachner, 2003; 
Lutchman et al., 2002; Robinson and Bonifacino, 2001; van Horck et al., 2001; Yamaz


































Figure 18: Schematic representation of the dopamine transporter proteome: Proteins 
found in the dopamine transporter complex are shown. Proteins shown in gray were not 
found in our studies but are known to exist in a complex with one or more proteins that 









The identification of DAT associated proteins can give us valuable insight into 
signal transduction pathways that regulate DAT function. For example, one of the 
proteins identified as part of the DAT complex is the small G protein RasGRF2. 
RasGRF2 is a Ca2+ -responsive guanine nucleotide exchange factor. RasGRF2 contains a 
calmodulin-binding site that is thought to regulate its Ca2+ sensitivity. The function of 
various monoamine transporters is regulated by intracellular Ca2+ levels. There is also 
evidence that DAT function is rapidly upregulated by intracellular Ca2+ (Uchikawa et al., 
1995).  The mechanism of this upregulation is currently unknown. A hypothesis that 
could be formulated and easily tested based on our proteomics data is that Ca2+-induced 
upregulation of DAT function is dependent upon RasGRF2. 
Correlation between gene expression profiles and protein interaction datasets has 
not been very well studied in complex multicellular organisms. Studies in yeast suggests 
that a correlation exists between gene expression profiles and protein interaction datasets 
(see (Ge et al., 2003) for review). Recently this finding in yeast was extended to the 
ing 
 
 can be hypothesized that the gene expression patterns of the 21 DAT-associated genes 
re part of a common transcriptome cluster. To test this hypothesis we used the WebQTL 
atabase. In silico investigation using WebQTL databases provided evidence for potential 
nctional relationships among the 21 DAT-associated proteins detected by mass-
ectrometry in the present study. Principal component analysis suggested the expression 
f the 21 DAT-associated genes is co-regulated. WebQTL can also be used to investigate 
C.elegans proteome and transcriptome data. It was found that genes encoding interact

















gene expression profiles of the 21 DAT-associated genes and DAT –related phenot
(like DAT density in different brain regions, cocaine –induced locomotor activity
cocaine induced stereotopy) suggested involvement of several genes in DAT function. 
These are correlational studies and hence need to be interpreted cautiously. The benefit
WebQTL analysis is that it can potentially help in narrowing down the list of candidate 
proteins for future investigations. 
A comparison of the components of the DAT proteome with that of the other 
brain proteomes published revealed very few overlaps. There are only 8 proteins that 
overlap between the DAT proteome and that of the PSD-95 p
k 375 proteins). DAT and the NMDA receptor proteome have only 3 proteins in 
common. Further, while the NMDA receptor proteome is composed of both pre- and 
post-synaptic components, no proteins that were exclusively post-synaptic were detected 
in the DAT proteome. This is significant because it implies that members of the DAT
proteome are discrete and specific.  
The identification of the components of the DAT proteome has raised several 
important questions. The molecular size of the DAT complex isolated needs to be 
determined by techniques like gel filtration. This information is important since it could 
reveal if DAT is part of a single large network of proteins or composed of several smaller 
networks. It is also important to determine if members of the DAT proteome co-lo
to the same cellular compartment. Our studies suggest that Kv2.1and DAT are localized 
to the presynaptic compartment. The subcellular localization of the remaining 
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components of the DAT proteome needs to be examined. One of the caveats of detergen
based extractions to isolate protein complexes is that they could lead to potential 
artifactual interactions. One way to overcome this problem is to isolate the DAT 
protoeme from synaptosomal membranes which are prepared free of detergents. The 
number of DAT–associated proteins reported in this study is a conservative estimate and 
is likely to increase with more sophisticated protein separation and sensitive mass 
spectrometry techniques. It would 
t 
be of interest to compare the DAT proteome with that 
of othe late 
e 






r neurotransmitter transporters to evaluate if common signaling pathways regu
the function of these transporters. DAT function is known to differ between brain 
regions. It would also be of interest to examine if differences in the components of the 
DAT proteome in different brain regions could account for these observations. Several 
strains of mice and rats differ in their ability to consume alcohol: for ex. the alcohol 
preferring (P) and non preferring (NP) rats. It would also be interesting to examine if 
DAT proteome differs between different strains and if the differences in DAT proteom
can account for behavioral difference
ed is whether the DAT proteome differs between wildtype and G130T transpor
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